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ABSTRACT
Coronavirus disease 2019 (COVID-19) has infected over 539 million
individuals worldwide, and initial research supports the possibility that COVID-19
may damage the central nervous system either directly or indirectly. Neurological
signs and noted cognitive deficits observed in even mildly infected patients are a
cause for concern for those infected by COVID-19; the effect of social isolation
on the central nervous system is also of interest. The present study sought to
determine the extent of these potential cognitive deficits in a young and mildly
infected sample of college students. Participants completed an extensive survey
assessing their experience with COVID-19 and any pandemic-induced social
isolation. Participants then completed a battery of cognitive assessments to
evaluate attention, memory, and executive functioning. Results largely suggested
that mild infection did not cause lasting cognitive deficits. While social isolation
largely did not influence cognition, it had an effect on non-diagnostic measures of
certain mental health disorders. Overall, the present data suggest no evidence of
current Long-COVID related cognitive deficits in a young and mildly infected
sample, despite participants reporting perceived deficits in their cognition. This
perceived lack will be important for clinicians and researchers to consider as the
COVID-19 pandemic continues to develop.
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CHAPTER 1
INTRODUCTION
1.1 BACKGROUND
Coronavirus disease 2019 (SARS-CoV-2, COVID-19) has infected over
566 million individuals worldwide, leading to 6.3 million COVID-19 linked deaths
(WHO “COVID-19 Dashboard”, obtained July 26th, 2022). COVID-19 has since
been declared the sixth public health emergency of international concern
(Williams et al., 2021). Official identification of the novel coronavirus occurred in
early January 2020. During this initial period, important aspects about SARSCoV-2 were discovered, including its interaction with angiotensin-converting
enzyme 2 (ACE2), its ability to replicate in many species, and its initial symptoms
of infection. Fever, cough, fatigue, pneumonia, increased plasma cytokines and
chemokines, and its extreme transmissibility were identified in the early patients
of COVID-19 in Wuhan, China (Huang et al., 2020; Jotz et al., 2020). Six weeks
after declaring COVID-19 a Public Health Emergency, on March 11th, 2020, the
World Health Organization declared COVID-19 a pandemic. In March of 2020, it
was first identified that SARS-CoV-2 induces increased levels of proinflammatory cytokines and chemokines without triggering a host’s immune
response (Blanco-Melo, 2020). Also during March, worldwide “stay at home”
orders and mandatory quarantine and social-distancing measures were put into
place. In April of 2020, unemployment increased, mostly in low-wage industries
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(CBPP, 2022). Drastic increases in mental health issues (namely anxiety and
depression) in the general population were observed as early as July of 2020
(CDC “Anxiety and Depression”). In December of 2020, the first variant was
identified, and since then at least five major variants have been discovered. It
was not until the beginning of 2021 that vaccines were readily available, but as of
May of 2022, only 66% of the United States population is considered fully
vaccinated (CDC “COVID Data Tracker”). Treatments and “cures” for COVID-19
are still limited, and vaccination is currently considered the top way to protect
oneself from COVID-19 (Cai et al., 2020).
1.2 COVID-19 OVERVIEW
COVID-19 is the seventh of the coronaviruses known to infect humans.
Four of the coronaviruses lead to mild illness while the remaining three (SARSCoV-1, MERS-CoV, SARS-CoV-2/COVID-19) can lead to more severe and
potentially deadly illness (Williams et al., 2021; Bougakov et al., 2021). SARSCoV-1 infected more than 8000 people worldwide during the 2002-2004
outbreak, and MERS-CoV had a mortality rate of almost 35% (Guadarrama-Ortiz
et al., 2020). SARS-CoV-2 has a higher transmission rate than both (Williams et
al., 2021).
Common symptoms of COVID-19 include fever, cough, fatigue, difficulty
breathing, and in more severe cases respiratory failure or pneumonia (Almeria et
al., 2020; Guadarrama-Ortiz et al., 2020). One of the more unique symptoms of
COVID-19 displayed is loss of smell (anosmia); this symptom was often one of
the first, and most salient, signs that someone had contracted COVID-19
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(Almeria et al., 2020; Bougakov et al., 2021; Guadarrama-Ortiz et al., 2020;
Graham et al., 2021). However, with more recent variants of COVID-19, anosmia
is not always present (CDC “What You Need to Know About Variants”).
COVID-19, similar to SARS-CoV-1, enters cells using angiotensin 2
(ACE2) (Almeria et al., 2020; Boldrini et al., 2021). SARS-CoV-2 attaches to
ACE2 using its spike protein, allowing its RNA to enter the cell (Shang et al.,
2020). ACE2 receptors are present in bronchial epithelial cells, endothelial cells,
on the surface of other organs (lungs, kidneys, heart, etc.), and in neurons (Li et
al., 2020). SARS-CoV-2 mainly affects the lower respiratory tract, causing
respiratory symptoms in 85% of patients with COVID-19 (Guadarrama-Ortiz et
al., 2020).
While many fully recover from COVID-19 within 2 weeks, others
experience symptoms of COVID-19 for an extended period. “Long-COVID,”
“long-haul COVID,” or “post-COVID conditions” (PCC) is defined by the CDC as
“signs or symptoms that develop during or after infection consistent with COVID19, continue for more than 12 weeks and are not explained by an alternative
diagnosis” (“COVID-19 Rapid Guideline”, 2020). However, definitions for LongCOVID, PCC, and long-haul COVID are mixed, sometimes with these terms
being used to describe different conditions rather than being used
interchangeably (Stefanou et al., 2022; Garg et al., 2021a). Other definitions for
PCC include: having recovered from the acute phase of COVID-19 but displaying
either lingering symptoms or new symptoms months after infection (Williams et
al., 2021), ongoing symptomology that persist for more than 12 weeks (NHS
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“Long-term effects of coronavirus (long COVID)”), having one persisting physical
symptom for a minimum duration of 12 weeks (Stephenson et al., 2022), new or
persistent symptoms occurring 4 weeks after acute infection (Walker et al.,
2021), the “time lag between microbiological recovery and clinical recovery”
(Raveendran et al., 2021), a “multi-organ disorder with a wide spectrum of clinical
manifestations” (Stefanou et al., 2022), and “signs and symptoms that emerge
during or after an infection consistent with COVID-19, persist for more than 12
weeks, and are not explained by an alternative diagnosis” (NICE).
The current literature does not always describe later observed deficits or
symptomology as being a part of PCC, which creates an artificial divide in the
current research. In brief, even when deficits are observed at a later date in a
certain sample or population, these deficits are not always attributed to being a
part of a “Post-COVID Condition.” Even clinically, PCC is not always correctly or
consistently diagnosed (Walker et al., 2021). Many of the symptoms associated
with PCC are nonspecific and are present in the never-infected general
population, with controls and previously infected individuals reporting “symptoms
of PCC” at similar rates (Amin-Chowdhury et al., 2021).
Many of the cases thus far associated with PCC have been self-reported
and broadly defined, as currently no official diagnostic tools exist to diagnose an
individual with PCC (Hampshire et al., 2021). According to the CDC, “PostCOVID Conditions” encompass a wide range of symptoms, such as fatigue,
difficulty thinking or concentrating (brain fog), malaise, shortness of breath, heart
palpitations, headache, dizziness, depression, anxiety, diarrhea, skin changes, or
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changes in menstrual cycles (CDC “Long COVID or Post-COVID Conditions”).
The research cited herein are a blend of data specifically designated as
contributing to the literature for “Long-COVID” or PCC and data that have not
been specifically designated by their primary researchers as contributing to the
literature on PCC, due in part to the lack of a clear consensus on a definition for
what constitutes a PCC.
It is estimated that anywhere between 10-25% of COVID-19 infected
individuals may suffer from some form of PCC (Guo et al., 2022). A recent metaanalysis revealed that 3-6 months post-infection, fatigue was present in 30%,
breathing difficulties in 25%, sleep disturbances in 24%, and difficulty
concentrating in 22%. For those who were 6-9 months post infection, “effort
intolerance” was the most frequent symptom, at 45%, followed by fatigue at 36%,
sleep disturbances at 29%, and difficulty breathing at 25%. For those 9-12
months post infection, fatigue was the most commonly found symptom at 37%
prevalence, followed by difficulty breathing at 21%. Only fatigue persisted as a
common symptom at 12 months post infection, at 41% prevalence (Alkodaymi et
al., 2022). Cognitive disorders were only found in 14% of those 3-6 months post
infection and in 15% of those 6-9 months post infection (Alkodaymi et al., 2022).
However, the rate of cognitive difficulties was higher in a different meta-analysis,
with rates of 20-30% in a non-hospitalized population and 30% in a hospitalized
population (Ceban et al., 2022). In children, the most frequently endorsed
symptoms were headache and fatigue (Molteni et al., 2021). PCC are more likely
to develop when an individual has experienced more severe COVID-19 infection
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or in individuals who required hospitalization for COVID-19, but PCC can still
occur in individuals who have not been hospitalized (Ziauddeen et al., 2022;
Townsend et al., 2021; Chen et al., 2022; Del Corral et al., 2022), who were
mildly infected (Townsend et al., 2021), and who are young (Zimmermann et al.,
2022; Stephenson et al., 2022; Molteni et al., 2021).
1.3 NEUROLOGICAL AND PSYCHIATRIC SYMPTOMOLOGY
Neurological symptoms of COVID-19 were first noted in late March 2020,
presenting in the form of loss of taste and/or smell (Carvalho et al., 2021).
Neurological symptomology associated with the COVID-19 virus is present in
around 30-80% of positive cases (Rogers et al., 2021; Bougakov et al., 2021).
Neurological symptoms can occur independently of respiratory symptoms and
can continue to occur months after respiratory symptoms have resolved,
indicating independent and ongoing nervous system involvement (Boldrini et al.,
2021).
Further evidence to support neural damage relating to the COVID-19 virus
is found in the host of neurological and psychiatric symptoms associated with the
virus. Neurological symptoms seem to occur early in the disease (RomeroSanchez et al., 2020; Bougakov et al., 2021). The proportion of patients affected
by neurological symptoms varies. Thus far, presence of neurological symptoms
and complications have been found in varying proportions of COVID-19 patients:
36% of middle-aged, hospitalized, mixed severity patients (Mao et al., 2020),
54.8% of all ages, hospitalized patients (Cai et al., 2020), 21% of intensive care
unit admitted, older adults (Kandemirli et al., 2020), and 57% of hospitalized,
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older adults (Romero-Sanchez et al., 2020), for example. A meta-analysis to
determine the frequency of neurological manifestations in COVID-19 patients
published in late 2021 analyzed 350 studies. Interestingly, only 11% of the
studies contained non-hospitalized participants. This meta-analysis estimates
about 30% of COVID-19 patients will display some kind of neurological
symptomology, with older populations and those more severely infected
displaying more neurological symptoms (Misra et al., 2021). Another recent
literature review estimates the prevalence of neurological symptoms at 21.3% for
hospitalized COVID-19 patients (Cagnazzo et al., 2021). For non-hospitalized
patients, prevalence of neurological manifestations has also been mixed: 46.7%
prevalence for CNS specific manifestations (Ding et al., 2020), 52% for homeisolated young adults (Blomberg et al., 2021), 38.2% for middle aged adults
(Pérez-González et al., 2022), and even up to 81% for middle aged adults
(Hugon, 2022) to name a few. Fatigue has also been shown to be more
frequently endorsed by non-hospitalized COVID-19 infected individuals (20.9%
prevalence as compared to 5.3%) (Pérez-González et al., 2022). Uniquely, one
study showed that both COVID-19 positive and never infected COVID-19 groups
showed relatively equal prevalence of brain fog, fatigue, and impaired cognition,
suggesting that factors other than infection could also be at play (Graham et al.,
2021).
It has been found that neurological symptoms seem to correlate to
disease severity, where patients who are more severely affected by the COVID19 virus are more likely to experience neurological symptoms (Whittaker et al.,
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2020; Majolo et al., 2021; Misra et al., 2021). The neurological symptoms
observed in clinical COVID-19 populations include stroke (Nannoni et al., 2021),
encephalopathies (Garg et al., 2021b), inflammatory syndrome (Hoste et al.,
2021), elevated cerebrospinal fluid antibodies (Tandon et al., 2021), headache
(Almeria et al., 2020; Bougakov et al., 2021, Mao et al., 2020; Graham et al.,
2021), microbleeds (Hampshire et al., 2021), seizures (Boldrini et al., 2021;
Bougakov et al., 2021), hypoxia (Hampshire et al., 2021), and brain fog (Hygon
et al., 2022; Graham et al., 2021).
Psychological and psychiatric consequences have also been observed
(Mendez et al., 2022; Hampshire 2021; Cai et al., 2020; Guadarrama-Ortiz et al.,
2020; Pennix et al., 2021; Mendez et al., 2021), some of which persisted for
months after hospital discharge. Specifically, anxiety and depression are acutely
present (Maley et al., 2022; Hao et al., 2020; Vannorsdall et al., 2022; Dondaine
et al., 2022; Boldrini et al., 2021; Cai et al., 2020; Mazza et al., 2021; Graham et
al., 2021; Mendez et al., 2021; Kujawa et al., 2020; Luo et al., 2020). During the
COVID-19 pandemic, rates of depression and anxiety have increased within
many populations, as seen in citizens from Denmark, (Sønderskov et al., 2020),
Ireland (Hyland et al., 2020), Istanbul (Özdin et al., 2020), Hong Kong (Choi et
al., 2020), and the United States (Kujawa et al., 2020). Potential comorbid
interactions of depression and anxiety with the COVID-19 virus cannot be
ignored (Cai et al., 2020; Méndez et al., 2021; Mazza et al., 2020). Worldwide,
anxiety and depression are the highest in patients either with COVID-19 or at
high risk for COVID-19 (Luo et al., 2020). Women have been found to be more
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psychologically affected than men in several studies of anxiety and depression in
the context of COVID-19 (Özdin et al., 2020; Sønderskov et al., 2020; Hyland et
al., 2020; Elbay et al., 2020; Lebel et al., 2020). SARS-CoV-1 survivors similarly
experienced psychiatric complaints after hospital discharge (Cai et la., 2020).
Cognitive impairment in survivors of acute respiratory distress syndrome has
been found to still have a 20% prevalence rate up to 5 years after hospital
discharge (Herridge et al., 2016).
Neuropsychiatric symptoms have been found to persist in anywhere
between 20-79% of patients up to several months past the recovery from viral
symptoms (Mendez et al., 2022; Boldrini et al., 2021; Majolo et al., 2021; Poletti
et al., 2021). However, some studies have found resolution of these symptoms
with time, with a range from 6 weeks to 9 months before full resolution (Guo et
al., 2022; Williams et al., 2021; Zhao et al., 2022; Mazza et al., 2021; Ferrucci et
al., 2021; Kujawa et al., 2020). Other studies have suggested that the
neuropsychiatric symptoms associated with hospitalized COVID-19 survivors is
due more to hospitalization rather than the infection itself (Nersesjan et al.,
2022). The presence of neurological and psychiatric symptoms in COVID-19
patients supports the theory that COVID-19 can affect the central nervous
system.
1.4 CNS INVOLVEMENT OF COVID-19
Although it is clear that COVID-19 can affect nervous system function, the
specific mechanisms by which it does so are still under investigation. At present,
there is substantial evidence that COVID-19 is neurovirulent (i.e., able to cause

9

changes in the nervous system that lead to disease), some evidence that it is
neuroinvasive (i.e., able to enter the nervous system), and minimal evidence that
it is neurotropic (i.e., able to infect and replicate within cells of the nervous
system), but exact mechanisms are still unknown and require further
investigation; few firm conclusions can be drawn at this time.
To be neuroinvasive, SARS-CoV-2 would need to enter the nervous
system. It is hypothesized that SARS-CoV-2 may be able to enter the central
nervous system directly through the nasal mucosa and olfactory tract, vagal
nerve, or trigeminal pathway (Krasemann et al., 2022; Orsini et al., 2020;
Bougakov et al., 2021; Boldrini et al., 2021; Guadarrama-Ortiz et al., 2020). The
proposed method of entry by SARS-CoV-2 begins in the nasal cavity, and
continues through the olfactory nerve, olfactory bulb, piriform cortex, and
eventually the brainstem. This same route of entry has been observed in 229E
and OC43, other coronaviruses (Arbour et al., 2000).
ACE2 is expressed in neurons and glial cells (Li et al., 2020; Bougakov et
al., 2021; Williams et al., 2021). If SARS-CoV-2 can gain entry to the CNS,
through the olfactory nerve or a damaged blood-brain barrier, then the virus
could potentially directly infect neurons. SARS-CoV-1 has previously been
detected in neurons of the hypothalamus and cerebral cortex, with a heavy viral
load detected in the brainstem (Gu et al., 2005; Williams et al., 2021). Mice
transgenic for human ACE2 displayed brain invasion of SARS-CoV-2, which
resulted in death within days (Orsini et al., 2020). In these mice, the piriform
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cortex and olfactory regions were the first to become infected (Orsini et al.,
2020). Other mice models have shown similar neuroinvasion (Song et al., 2021).
Another possible entryway into the CNS might be through the blood-brain
barrier with the assistance of inflammatory cytokines or monocytes due to the
instability of the barrier caused by inflammation; SARS-CoV-2 is able to directly
damage endothelial cells, and entry of SARS-CoV-2 into the CNS via endothelial
cells has been observed (Boldrini et al., 2021; Varga et al., 2020; Hang et al.,
2021; Krasemann et al., 2022). SARS-Cov S protein has also been observed in
the cytoplasm of endothelial cells (Meinhardt et al., 2021). SARS-CoV-2 RNA
has been observed in the cerebellum, trigeminal ganglion, olfactory bulb, and
olfactory mucosa (Meinhardt et al., 2021; Molina-Gil et al., 2021). SARS-CoV-2
proteins have been detected via immunohistochemistry in vagus nerve fibers and
the choroid plexus epithelium (Bulfamente et al., 2021; Gomes et al., 2021;
Pellegrini et al., 2020). SARS-CoV-2 RNA has also been detected in blood
serum; detection of this RNA occurs in 90% of patients who develop “critical
disease,” and is found in only 50% of patients who develop moderate or severe
disease (Jacobs et al., 2022; van Riel et al., 2021). In general, SARS-CoV-2
RNA has been detected in 2.5% of sampled brain regions in only 20% of cases
(Serrano et al., 2022), in 71.4% of cases using PCR, immunohistochemistry,
electron microscopy, and in situ hybridization (Meinhardt et al., 2021), in brain
tissue of a case study of a child infected with COVID-19 (Gomes et al., 2021),
and in brain organoids (Song et al., 2021; Zhang et al., 2020; Bullen et al., 2020).
While much of this work suggests that SARS-CoV-2 may be able to enter the
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nervous system directly, through either the cranial nerves or by passing through
the blood brain barrier, it is largely still hypothetical at this point and it remains
unclear what role, if any, such direct infection of the CNS plays in COVID-19
symptoms and PCC.
To be neurotropic, SARS-Cov-2 would need to be able to infect and
replicate in cells of the nervous system. SARS-CoV-2 has also been detected in
cortical neurons of autopsied individuals and in human cortical astrocytes of
human stem-cell-derived organoids (Song et al., 2021; Andrews et al., 2022).
Neurotropism has been detected in the olfactory mucosa and in olfactory sensory
neurons (de Melo et al., 2021). Stem cell derived midbrain dopaminergic neurons
have also been found to be selectively permissive to SARS-CoV-2 infection in
vitro and in vivo (Han et al., 2021). However, others have found no evidence of
productive infection or CNS involvement (Bauer et al., 2021; Schaller et al., 2020;
Solomon et al., 2020).
To be neurovirulent, SARS-CoV-2 would need to be able to cause
pathology in the CNS that contributes to disease of the nervous system; this
pathology can be independent of neuroinvasiveness or neurotropism. That is,
SARS-CoV-2 could indirectly lead to changes in nervous system function by
affecting other systems in the body.
COVID-19 infection has been shown to increase levels of inflammatory
cytokines, which can activate glial cells once crossing over the blood-brain
barrier and even weaken the blood-brain barrier itself (Boldrini et al., 2021;
Almutairi et al., 2016; Erickson et al., 2012). Increased serum levels of
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proinflammatory cytokines (such as interleukins 1, 4, 6, 10, and tumor necrosis
factor alpha) have been observed in patients with severe COVID-19 (Luporini et
al., 2021; van Riel et al., 2021; Boldrini et al., 2021; Pennix et al., 2021; Mazza et
al., 2021; Guo et al., 2020). Proinflammatory cytokines, chemokines, and
macrophages seem to have a significant role in the advancement and severity of
COVID-19 (Andrews et al., 2022; Sodagar et al., 2022; Williams et al., 2021).
SARS-CoV-2 induces systemic inflammation, which can in turn induce activation
of microglia in the CNS (Bulfamante et al., 2021; Boldrini et al., 2021; Pennix et
al., 2021; Han et al., 2021). Direct evidence of activated microglia, microglial
clusters, astrogliosis, and extensive inflammation have been observed in COVID19 patients (Lee et al., 2021; Schurink et al., 2020; Matschke et al., 2020).
Elevated levels of these chemicals can lead to dysregulation of neurotransmitter
release, decreased neurogenesis, neurodegeneration, or even to cytokine storm
syndrome (Boldrini et al., 2021; Williams et al., 2021; Orsini et al., 2020). Postmortem studies of individuals who died from COVID-19 indicate evidence of
ischemic lesions and neuroinflammation (Guo et al., 2022). The effects of chronic
neuroinflammation through activated glial cells are detrimental, and well-studied
(Schain et al., 2017; Streit et al., 2004).
Higher levels of bilateral grey matter volume have been detected in the
hippocampi of COVID-19 patients, while loss of grey matter has been observed
in areas connecting to the olfactory cortex; white matter changes have also been
observed (Majolo et al., 2021; Guo et al., 2022; Hampshire et al., 2021;
Bougakov et al., 2021). Neuroimaging data shows that the medial temporal lobe
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is the most vulnerable to COVID-19 (Moriguchi et al., 2020; Poyiadji et al., 2020).
MRI findings from COVID-19 patients in the intensive care unit showed
abnormalities in the frontal, parietal, occipital, and temporal lobes, in addition to
the insular cortex and cingulate gyrus (Kandemirli et al., 2020). Hemorrhagic
lesions have also been observed in many of these areas, specifically the
orbitofrontal cortex, the medial temporal lobe, hippocampus, thalamus, and
insular cortex (Guo et al., 2022). Microglial nodules and neuronophagia has been
detected in the brain stem, cortex, and limbic structures (Boldrini et al., 2021). It
has even been proposed that respiratory issues observed in COVID-19 patients
may be caused by SARS-CoV-2 infecting the respiratory centers of the medulla
and pons (Li et al., 2020). Viral RNA from SARS-CoV-2 has been detected in the
medulla, cerebellum, the area postrema, the olfactory cortex, and in cerebral
spinal fluid (Boldrini et al., 2021; Meinhardt et al., 2020; Bougakov et al., 2021).
Hospitalized COVID-19 patients showed levels of neurodegenerative biomarkers
(such as tau, GFAP, and NfL) at levels higher than Alzheimer’s patients (Frontera
et al., 2021 at NIH convention). However, other studies have shown no detection
of SARS-CoV-2 in cerebral spinal fluid (Pezzini et al., 2020).
Secondary mechanisms of brain damage, such as through hypoxia or
blood clotting, are also possible (Bougakov et al., 2021; Orsini et al., 2020;
Pennix et al., 2021). Those more seriously infected with COVID-19 might be at
risk for strokes, hypoxia, or encephalitis, which alone can cause neurocognitive
impairment. The overall effects of stress stemming from excessive worries about
COVID-19 such as fears surrounding misinformation or confusing information,
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employment uncertainties, stigma surrounding infection, or fear of infecting
others cannot be understated, as sustained stress is capable of dysregulating the
hypothalamic-pituitary-adrenal (HPA) axis (Cai et al., 2020). Dysregulation of the
HPA axis leads to body-wide dysregulation of hormones and neurotransmitters,
which could serve as an unforeseen consequence of COVID-19 related stress.
1.5 COGNITIVE COMPARISONS BETWEEN OTHER VIRUSES
Several other viruses have neuronal consequences, are neuroinvasive, or
otherwise affect the CNS. Evidence of neuronal consequences and cognitive
outcomes from other viruses can provide a basis for what can be expected from
COVID-19 infection.
Herpes simplex virus type 1 (HSV-1) is capable of infecting nerve tissue;
upon activation of the virus, it can infect the CNS (De Chiara et al., 2019). It is
believed that HSV-1 infects the CNS through the bloodstream or the trigeminal
nerve (Gnann and Whitley, 2017). In HSV-1 infected mice, higher levels of
neuroinflammatory biomarkers were detected in conjunction with cognitive
impairment (De Chiara et al., 2019). In humans, HSV-1 DNA was detected in the
temporal cortex and hippocampus (Jamieson et al., 1992). In serious cases,
HSV-1 can cause encephalitis, which in turn can lead to cognitive impairment,
specifically impairments of memory (Gnann and Whitley, 2017; Bougakov et al.,
2021).
Human immunodeficiency virus type 1 (HIV-1) is a highly virulent and
infectious lentivirus. HIV-1 can gain access to the nervous system as soon as
two weeks after primary infection (Atwood et al., 1993). HIV-1 gains access to
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the CNS through infected monocyte-derived macrophages, where it crosses the
blood-brain barrier (Atwood et al., 1993; McArthur et al., 2005; Sanmarti et al.,
2014; Rao et al., 2014). Once established in the CNS, infected cells secrete
chemokines which recruit additional monocytes from the periphery as part of an
inflammatory response (Sanmarti et al., 2014; Rao et al., 2014; Woods et al.,
2009). The virus itself can infect other monocytic cells within the CNS, such as
perivascular macrophages, microglia, or astrocytes (Atwood et al., 1993; Rao et
al., 2014, Swanstrom et al., 2012, Woods et al., 2009).
Within 60 days, some HIV-1 positive individuals display neuroinflammation
(Lentz et al., 2009; He et al., 2014). Within 100 days, structural brain changes
such as decreased brain volume and decreases in white matter have been
identified (Saylor et al., 2016). Damage worsens with time, and HIV-1 damages
both macro (frontal, temporal, and parietal cortices, white matter tracts), and
micro (neuronal apoptosis, loss of dendrites and synapses) processes in the
brain directly through the release of viral proteins, and indirectly through
inflammatory cascades (Woods et al., 2009; Rao et al., 2014). Despite
antiretroviral treatment, the virus’s presence in the CNS does not diminish
(Saylor et al., 2016). In fact, compartmentalized versions of the virus have been
found in brain tissue at autopsy, indicating that the virus is capable of
independent replication in the CNS despite lack of replication in the periphery
(Swanstrom et al., 2012). After 10 years of antiretroviral therapy, low levels of
HIV-1 RNA were still able to be detected in cerebrospinal fluid (Carroll et al.,
2017). The virus can be detected in brain tissue at autopsy, brain tissue being
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the second most infected tissue after the lungs (Swanstrom et al., 2012, Woods
et al., 2009). It is theorized that the virus can enter a state of latency after first
entering the CNS, since most clinically relevant signs of neurocognitive disease
do not appear until years after primary infection (He et al., 2014). Unchecked
virus in the CNS can lead to acute meningitis, meningoencephalitis, or AIDS
dementia complex; even with combined antiretroviral therapy, complications such
as HIV-1 associated neurocognitive disorders (HAND) can arise. HAND is an
example of an after-effect of a virus that can occur from months to years to
decades after initial infection, and its existence prompts potential cause for
concern that COVID-19 may be capable of the same.
West Nile Virus (WNV) is a neurotropic flavivirus. It is hypothesized that
WNV enters the central nervous system either through direct infection of
endothelial cells or through the olfactory nerve, where it is then able to directly
infect neurons and glial cells (Davis et al., 2006). More serious forms of WNV can
lead to encephalitis and meningitis, but even mild forms of WNV are associated
with neurological symptomology (Davis et al., 2006). Cognitive deficits in multiple
domains and neuropsychiatric issues were observed up to a year past onset of
symptoms (Hughes et al., 2007; Hart et al., 2014; Hawkes et al., 2018; Sadek et
al., 2010; Davis et al., 2006).
Three other coronaviruses (SARS-CoV-1, 229E, and OC43) are
neuroinvasive and neurotropic (Pezzini et al., 2020). Other coronaviruses have
been shown to cause direct damage to the CNS, such as through peripheral
demyelinating illness (Bougakov et al., 2021). MERS specifically has shown

17

increased rates of depression and PTSD in survivors (Park et al., 2020). The
hippocampus, a brain structure heavily involved with learning and memory, is a
target of viral encephalopathies for SARS-CoV-1, HSV encephalopathy, HIV-1
encephalopathy, and potentially SARS-CoV-2.
1.6 COGNITIVE OUTCOMES
In general, cognitive deficits have been found to persist for months up to a
year past COVID-19 infection (Crivelli et al., 2022; Vannorsdall et al., 2022;
Dondaine et al., 2022; Ferrucci et al., 2022; Liu et al., 2022; Ziauddeen et al.,
2022; Nersesjan et al., 2022; Del Corral et al., 2022). Based on the symptoms
associated with the aforementioned neurotropic viruses, and the current
evidence for COVID-19, the following domains of cognition were selected for
analyses for the present study: attention, memory, and executive functioning (as
assessed by cognitive flexibility and decision making).
There are many components of attention, which is the aspect of cognition
that allows the collection and initial organization of information from the
environment. Properly functioning attention is characterized by one’s ability to
focus selectively on a stimulus, hold focus on that stimulus, and shift to focusing
on other stimuli as necessary. Deficits in attention can lead to the inability to tune
out unimportant details or the inability to focus on details important the task at
hand.
In both SARS-CoV-1 and MERS, survivors saw impairment of attention up
to 39 months after recovery (Mazza et al., 2021). In HIV-1 associated
neurocognitive disorder, attention is one of the main cognitive domains affected,
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with symptoms including reduced ability to shift attention, change focus, divide
attention, concentrate, and sustain attention to stimuli (Atwood et al., 1993,
Hinkin et al., 2000, Antinori et al., 2007; Chang et al., 2014). Attentional deficits
can cause difficulty in all areas of a patient’s daily life (Sanmarti et al., 2014).
Specifically, deficits in sustained attention have been shown to have a negative
effect on medication adherence, and even driving ability, in HIV-1 positive
individuals (Woods et al., 2009, Marcotte et al., 2006).
Deficits in attention have been observed in hospitalized COVID-19
patients requiring rehabilitation and oxygen treatments (Jaywant et al., 2021;
Almeria et al., 2020). Deficits in attention seem to become greater with disease
severity for COVID-19, wherein hospitalized patients have greater deficits than
those with milder symptoms (Hampshire et al., 2021). Patients presenting
neurological symptoms during COVID-19 infection also showed greater deficits in
attention 3 months after recovery than patients who did not present neurological
symptoms (Almeria et al., 2020). Even non-severely infected individuals saw
deficits in attention at a later time period (Dondaine et al., 2022). Patients
diagnosed with PCC, even if they have not been hospitalized, show significant
deficits in attention (Graham et al., 2021). Research specific to COVID-19
suggests that brain stem involvement of the COVID-19 virus may lead to deficits
in attention (Gandhi et al., 2020). There is also evidence to support that simply
the fear of the COVID-19 virus is enough to induce deficits in attention (Ismail et
al., 2021).
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For the present study, assessments of sustained attention and selective
attention were chosen. Sustained attention is a component of cognitive capacity
that allows maintenance of the ability to detect infrequent, weak, or unpredictable
stimuli over a long period of time (Levine et al., 2006; Sarter et al., 2001).
Continuous performance tasks often involve a participant attending to continuous
stimuli (such as presentation of images or tones) for a long period of time; the
participant is expected to attend to all stimuli and correctly respond to only the
target stimulus as quickly as possible (Roebuck et al., 2016). Deficits in
sustained attention have been observed in those infected with the neuroinvasive
West Nile virus (Fromm et al., 2015). Preliminary data has also shown that
vigilance deficits occur in COVID-19 survivors (do Carmo Filho et al., 2022; Zhao
et al., 2022).
To assess sustained attention in the present study, a vigilance task was
used. Alertness is an important component of vigilance, and alertness is known
to be modulated by norepinephrine and metabolic chemicals such as glucose,
oxygen, and thyroid hormones (Oken et al., 2006). Stress, sleep, and apathy are
other factors that can influence vigilance ability (Oken et al., 2006). Sustained
attention is thought to be modulated by the right middle frontal gyrus, the right
parietal lobe, the amygdala, and the HPA axis (Lewin et al., 1996; Oken et al.,
2006).
Selective attention reflects the process of attending to a particular object
or stimulus. Those with deficits in selective attention may be unable to tune out
unimportant details and may have difficulty focusing on the task at hand. HIV-1
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positive patients exhibit selective attention deficits (Lew et al., 2018). Selective
attention deficits have also been observed in patients with West Nile virus
(Lambert et al., 2016). Unpublished data also suggests a deficit in selective
attention in COVID-19 survivors as assessed by the Eriksen Flanker Task (Kao,
2021). The Flanker Task was used for the present study. The Flanker Task is
used to assess visual attention and the ability to filter out distracting information
to focus on relevant information. Flanker Task performance is thought to be
modulated by the left middle frontal gyrus, the inferior parietal and frontal
cortices, anterior cingulate cortex, dorsolateral prefrontal cortex, and orbitofrontal
cortex (Salo et al., 2017; Luks et al., 2010; Rusnáková et al., 2011; vel
Grajewska et al., 2011).
Similar to attention, there are many facets of memory. Deficits in memory
are associated with difficulty in important aspects of everyday functioning, such
as decision making or reasoning, which can lead to a loss of independence. The
aspects of memory that will be discussed will be working memory, spatial
working memory, and memory capacity.
Working memory reflects the ability to create a temporary (or “working”)
memory for short-term processing and information storage (Schouten et al.,
2011). Working memory is also defined as the cognitive skill that allows an
individual to retain and manipulate information over a brief period of time; thus,
working memory is an essential process for the maintenance of concentration,
reasoning, learning, and planning. A commonly used assessment for verbal
working memory is the forward and reverse digit span memory task, which is
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used as part of the WAIS assessment for working memory. Digit Span
performance is thought to be mediated by the dorsolateral prefrontal cortex,
inferior parietal lobe, anterior cingulate cortex, and basal ganglia; of note, the
backward portion of the task is thought to rely more on visuospatial imagery than
the forward portion of the task, and additionally the backward portion activates
the dorsolateral prefrontal cortex more than the forward portion does (Aleman et
al., 2008; Geva et al., 2021; Hoshi et al., 2000). It is worth noting that working
memory and attention are often considered intermingled processes, with
attention serving as a “gatekeeper” for the information that is permitted to occupy
one’s working memory (Awh et al., 2006).
A subset of working memory is visuospatial working memory. Visuospatial
working memory represents the ability to temporarily retain visuospatial
information. A Delayed Match to Sample task is a commonly used assessment
for maintenance ability of visual information (Daniel et al., 2016). This task is
thought to be mediated by the dorsolateral prefrontal cortex, fusiform gyrus,
parietal cortex, and anterior cingulate cortex (Daniel et al., 2016; Habeck et al.,
2004; Cirillo et al., 1989). Working memory capacity reflects the amount of
information that can be reliably held for manipulation in one’s working memory.
Working memory capacity is important for completing any cognitive task because
of the need to hold information while it is being processed. Working memory
capacity can be a reflection of one’s processing ability, their ability to combine
new and old information, or their ability to use attention to maintain or suppress
certain information (Cowan, 2010; Engle, 2002). Working memory capacity,
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which is thought to be mediated by the parietal lobe and dorsolateral prefrontal
cortex, was assessed using a Change Detection task (Beck et a., 2001).
The effect of emotional valence on memory consolidation was also a focus
of the present study. It is known that negative and positive stimuli are encoded in
different ways and utilize different brain structures (Bowen et al., 2018). The left
superior prefrontal cortex, right fusiform gyrus, and ventral striatum are more
active when consolidating positive stimuli (Kuchinke et al., 2005; Lewis et al.,
2003; Wittmann et al., 2008) while the amygdala, sensory-processing regions,
and left inferior prefrontal cortex are more active when consolidating negative
stimuli (Bowen et al., 2018; Lewis et al., 2003). Regardless of valence,
consolidation of emotional information can be attributed in part to the left
orbitofrontal gyrus, bilateral inferior frontal gyrus, and hippocampus (Kuchinke et
al., 2005; Bowen et al., 2018). An emotional memory task was used to assess
any unique interactions that valence may have on memory for COVID-19
survivors. It has previously been found in socially isolated COVID-19 survivors
that positive bias in emotion recognition was reduced when compared to those
who had not been as socially isolated, regardless of infection status (Bland et al.,
2021).
In other neuroinvasive diseases, working memory dysfunction has been
identified as a predictor of poor medication adherence, unemployment, and low
independence (Chang et al., 2016; Woods et al., 2009). HIV-1 positive
individuals perform worse in measures of working memory and spatial memory
than HIV-1 negative controls; poorer working memory in these populations has
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been associated with elevated levels of inflammatory cytokines (Walker et al.,
2018; Wilson et al., 2017; Morales et al., 2012). Visual working memory has also
been shown to be impaired in West Nile Virus; HSV-1 encephalitis can also lead
to impairments in memory (Fromm et al., 2015; Bougakov et al., 2021). In both
SARS-CoV-1 and MERS, survivors saw impairment of memory up to 39 months
after recovery (Mazza et al., 2021). Deficits in memory have been observed in
recovered COVID-19 patients, and those with neurological symptoms had even
lower scores in working memory than those without neurological symptoms
(Vannorsdall et al., 2022; Alemanno et al., 2021; Becker et al., 2021; Graham et
al., 2021; Mendez et al., 2021; Hampshire et al., 2021; Jaywant et al., 2021;
Almeria et al., 2020). However, other studies in COVID-19 positive populations
indicated the lack of long-term working memory and emotional processing
deficits (Guo et al., 2022; Hampshire et al., 2021; Mattioli et al., 2021; Zhao et al.,
2022).
Cognitive flexibility is an aspect of executive functioning that reflects the
ability to adapt ones thinking or behavior to achieve a certain outcome; in other
words, if a certain pattern or response is not leading to success, proper cognitive
flexibility will allow the adaptation to a response that does allow for success. The
Wisconsin Card Sorting Task (or Berg’s Card Sorting Task) are assessments of
cognitive flexibility. They are also thought to assess set-shifting, which is an
important aspect of executive functioning that gives the ability to disengage from
familiar or relevant stimuli and actively engage with, or shift attention to, new,
previously irrelevant stimuli (Pennington & Ozonoff, 1996; Walker et al., 2018).
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Card Sorting Task performance is thought to be mediated by the ventrolateral
and dorsolateral prefrontal cortex, anterior cingulate cortex, and inferior parietal
lobe (Buchsbaum et al., 2005; Nagahama et al., 1996; Lie et al., 2006). Severity
of COVID-19 infection has been associated with Wisconsin Card Sorting Task
performance, wherein more severely infected individuals perform worse (Guo et
al., 2022). Deficits in executive function have been observed in COVID-19
recovered individuals, with those displaying neurological symptoms having even
greater deficits (Becker et al., 2021; Alemanno et al., 2021; Mazza et al., 2021;
Helms et al., 2020; Almeria et al., 2020). However, there is also some evidence
to support that executive functioning deficits may recover over time in COVID-19
recovered individuals (Guo et al., 2022; Mattioli et al., 2021; Zhao et al., 2022).
Decision making is an associated domain which involves the process of
selecting an option or belief based upon previously gathered information,
perception of possible outcomes, and/or the current situation. The Iowa
Gambling Task is a commonly used task to assess decision making and risktaking behavior. Brain regions thought to be involved in this task are the insula,
basal ganglia, the ventral and dorsal prefrontal cortex, the frontal gyrus, and the
lateral orbitofrontal cortex (Lin et al., 2008; Lawrence et al., 2009). In HIV-1,
decision making as assessed by the Iowa Gambling Task is found to be impaired
(Nakao et al., 2020). During the COVID-19 pandemic, it was found that
selections on the Iowa Gambling Task improved as lockdown restrictions were
eased, indicating the possible influence that social isolation may have on
decision making (Ingram et al., 2021).
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The social aspects of the COVID-19 pandemic could be just as impactful
as viral infection. Specifically, social isolation necessitated by mandated
quarantining was a shared experience despite COVID-19 viral status. Social
isolation can be defined as a deprivation of social connectedness (Zavaleta et al.,
2017). A positive social experience comes not only from the quality of one’s
social relations, but also through the frequency and quantity of these interactions
(Zavaleta et al., 2017). One could assume that individuals who are more
technologically literate and adjusted to online communication (such as young
adults) may not be as affected by the restriction of in-person socialization
activities. However, CDC data from June 2020 showed that young adults (i.e.,
those aged 18-24) were more likely to suffer from mental health problems than
other age groups; similar results were found by the Harvard Graduate School of
Education, wherein 61% of young adults reported feeling lonely as compared to
24% of adults aged 55-56 (Czeisler et al., 2020; Weissbourd et al., 2021). Young
adults who are pursuing higher education have additional unique stressors.
These can include the unexpected cancelling or format changes of coursework,
unknown living situations, instability of funding, or even feelings of “unjustness”
due to experiencing a different college experience than was expected (Zurlo et
al., 2020).
Social isolation is associated with a host of negative health outcomes,
such as poor cardiovascular health, worse mental health, impaired executive
functioning, impaired ability to focus, and poor sleep quality (Somma et al., 2021;
Pfefferbaum and North, 2020; Luo et al., 2020; Zovetti et al., 2022). Social
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isolation can cause stress, which activates the HPA axis; this can cause
cognitive deficits, increased psychological distress, and body-wide hormonal
dysfunctions. An early study showed that 31% of their sample of COVID-19
survivors met criteria for “excessive stress,” which has further been corroborated
by similar research (Ismail et al., 2021; Cai et al., 2020, Hao et al., 2020). In
addition, quarantining and “lockdowns” may also have led to sedentary behavior,
which is known to result in negative health outcomes (Stranahan et al., 2006; Cal
et al., 2020; Galea et al., 2020). Specific to the COVID-19 pandemic, following
long-term quarantine, rates of perceived stress rose, and cortisol was found to be
dysregulated (Baliyan et al., 2021).
Much of the research on social isolation in humans is in the elderly; in this
population, isolation is significantly associated with decreases in verbal fluency
and both delayed and immediate recall (Shankar et al., 2013). Loneliness has
also been found to negatively impact decision making and working memory in
older adults with pre-existing cognitive issues (Stewart et al., 2020). However,
social isolation has been found to be detrimental to neuronal health, memory,
and emotional regulation during development as well (Ibi et al., 2008; Cinini et
al., 2014; Ingram et al., 2021; Liu et al., 2020; Fone et al., 2008; Stranaham et
al., 2006). Social isolation may also disproportionately negatively affect
adolescents with ADHD (Navarro-Soria et al., 2021). Social interaction can be
considered a protective factor against cognitive decline, or even as a restorative
to help enhance cognition (Ingram et al., 2021; Zovetti et al., 2022; Evans et al.,
2018).
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In non-human primates, it has been found that social deprivation
specifically during the transition between adolescence to adulthood lead to
increased cortisol and decreased neurogenesis (Cinini et al., 2014). In mice,
adolescent isolation led to decreased survival of new neurons and decreased
object recognition when combined with pro-inflammatory cytokines (Hueston et
al., 2017). Functional and structural changes in the pre-frontal, temporal cortex,
parietal cortex, the limbic system, the cerebellum, and the striatum have been
found to be associated with loneliness and social isolation (Zovetti et al., 2022).
In the context of the COVID-19 pandemic and subsequence social isolation, it
was found that selections on the Iowa Gambling Task improved as lockdown
restrictions were eased (Ingram et al., 2021). It was also found that Flanker Task
reaction time improved as lockdown restrictions were eased (Ingram et al.,
2021). Thus, while the virus itself could be harmful to the brain and its functioning
in isolation, the social aspects of living through a pandemic may be just as
damaging.
The 2016 National Institute of Health’s “Sex as a Biological Variable”
policy serves as an important call to action to include biological sex as a factor in
research. There is evidence from other neuroinvasive viruses and diseases to
support that there may be sex differences within COVID-19 infection as well. For
example, HIV-1 positive women show impairments in memory, learning, and
information processing speed (Rubin et al., 2019). Impairments in attention and
calculation speed also were higher in women with HIV-1 than in men with HIV-1
(Qiao et al., 2019). While not a virus, in Alzheimer’s disease, women have shown
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greater cognitive deterioration than men in the domains of episodic, semantic,
verbal, and visuospatial memory (Laws et al., 2018).
Already, some sex differences have been observed for COVID-19. Males
with COVID-19 have higher levels of plasma immune cytokines than females,
while females have a more robust T-cell activation (Takahashi et al., 2020).
Specifically, pro-inflammatory cytokines such as interleukins 10, 15, and 8 were
higher in males; markers of brain injury were also found to be higher in males
with COVID-19 than in females with COVID-19 (Savarraj et al., 2021). In general,
it’s been found that males have less favorable outcomes for COVID-19 infection.
However, females show a higher prevalence of changes in smell and taste,
which may indicate increased neuroinvasiveness (Santos et al., 2021). Females
also show significantly more PCC symptoms than males (Fernández-de-LasPeñas et al., 2022).
Men more frequently presented with severe COVID-19 infection than
women, and they are at a higher risk of death (Bunders et al., 2020). Females
typically have a stronger immune response against viruses than males, perhaps
due to a stronger expression of antiviral mechanisms coded by the X
chromosome (Bunders et al., 2020). Specific to COVID-19, it has been
hypothesized that estrogen may downregulate the expression of ACE2, which
may account for some of the sex differences observed (Liu et al., 2010).
Previously hospitalized COVID-19 female patients were more likely to report
subjective declines in cognitive functioning than males (Ferrucci et al., 2021).
While not related to COVID-19 infection directly, it has also been found that

29

female health care workers have been disproportionately negatively affected in
the domains of depression and anxiety during the COVID-19 pandemic (Pappa et
al., 2020).
It is presently unknown what the long-term effects of COVID-19 infection
may be on overall health and cognition. It is also unknown the effect that COVID19 infection, or quarantine and mass shut-down events caused by COVID-19,
may have specifically to those still in development. The present study seeks to
determine the potential cognitive deficits that may have been caused by COVID19 infection, social isolation because of widespread quarantining, or a
combination of both. Since the majority of individuals that were infected with
COVID-19 were not seriously affected by the infection (i.e., to the point of
hospitalization), it is also of increased clinical relevance to sample from a
population that experienced more mild illness with COVID-19. In the present
study, several aspects of attention, memory, and executive functioning found to
be impaired in other viruses known to be neuroinvasive or neurovirulent were
assessed in young adults who were previously infected with COVID-19
compared to those who were previously uninfected. The impact of the social
aspects of COVID-19 (such as social isolation) were studied to determine their
influence on cognitive functioning. The present study is designed to build upon
prior research in neuroinvasive viruses by assessing the neurocognitive profiles
of those who have had COVID-19 and lived through the beginning of the COVID19 pandemic.
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1.7 SPECIFIC AIMS
The present study has three aims. Given that cognitive deficits are a
common symptom of PCC, the first aim is to determine the potential cognitive
consequences of COVID-19 infection in a young-adult sample that has fully
recovered from viral infection. Since social isolation can lead to changes in
cognition, the second aim is to determine the potential cognitive consequences of
social isolation induced by widespread quarantine measures. Given the evidence
for sex differences in the prevalence of PCC, the third aim is to determine the
potential interactions between COVID-19 and biological sex, and their potential
influence on cognition. These aims will be addressed through the analysis of an
extensive pre-experiment survey and cognitive battery
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CHAPTER 2
MATERIALS AND METHODS
2.1 ETHICS STATEMENT
The present research was conducted in accordance with the University of
South Carolina’s Institutional Review Board. The present study was exempt from
full review (ID: Pro00114536).
2.2 PARTICIPANTS
Based on an a priori power analysis, it was determined that approximately
84 participants were needed for 95% power to detect a large effect, 210
participants to detect a medium effect, and 1302 participants to detect a small
effect for the difference between COVID-19 infected and COVID-19 uninfected
groups, and the interaction between COVID-19 infection status and sex. In an
attempt to achieve the number of participants required for a medium effect size,
the study was made available on SONA (UofSC’s Department of Psychology’s
online participant pool) for students to participate between September 2021 and
April 2022, with an average of 10-12 available participation time slots per week
(for a total of ~330 available slots over 2 semesters). Informal communication in
the classroom and online was also used to inform students of study availability.
Participants received course credit through the SONA system for participation in
the study. Unfortunately, the required number of participants could not be
recruited with time to be included in the present research. Thus, although
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analyses were completed as planned with the participants obtained, results
should be interpreted with caution as the estimated power to detect a medium
effect was only 81.7% for the number of participants we obtained data from, and
less than 60% for any smaller effects.
A total of 81 participants completed both the online assessment and inperson cognitive assessment. If participants did not participate in both the online
assessment and the in-person cognitive assessment, their data were not used for
any further analyses. All participants were between the ages of 18 and 30 years,
with a mean age of 20.71 years. Participants were students enrolled at UofSC
who were fluent in English and had normal or corrected-to-normal vision and
hearing, with no individuals reporting color-blindness. The sample was 70.4%
female, 69.1% white/Caucasian (participants were allowed to select as many
races as they deemed fit), and 87.7% non-Hispanic or Latino. Participants were
tested between the hours of 10AM and 5PM. Additional demographic
information, COVID-19 experience, and psychiatric assessment information can
be found in Table 2.1. Information on severity of infection is based on the
answers for “Which of the following best describes your experience with COVID19,” a question from the Google Form (see Appendix A).
Consent to participate was obtained by the researcher, and all
questionnaires and screening questions were framed as requiring voluntary
responses only. Data collection and analyses were conducted at the Institute for
Mind and Brain building affiliated with the University of South Carolina’s
Psychology Department.
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2.3 STIMULI AND APPARATUS
The study consisted of two parts: an online survey and an in-person
cognitive assessment. After registering for the study, participants received a link
to a Google Form. The survey consisted of 190 questions and took
approximately 20 minutes to complete. The first portion of the survey assessed
previous COVID-19 infection status, vaccination status, and the symptoms
experienced by those who had previously been infected with COVID-19.
Participants were prompted to indicate whether they were officially diagnosed
with COVID-19 via nasal swab, blood test, or saliva test. Eight participants
indicated that they thought they had COVID-19 at some point but had not been
officially diagnosed. Only participants who indicated that they had also
experienced a loss of taste and smell were included in the “previously COVID-19
infected” group, as these symptoms are salient and unique to COVID-19 infection
(Almeria et al., 2020; Bougakov et al., 2021; Guadarrama-Ortiz et al., 2020;
Graham et al., 2021). Of the eight participants, four had experienced loss of
smell and taste and were placed in the “previously infected” group, while the
remaining four were placed in the “COVID-19 uninfected” group. All statistical
analyses were conducted both with these four individuals placed in the
“previously infected” and “uninfected” groups; the inclusion of these individuals in
either group did not alter the outcome any of the statistical tests.
All participants, regardless of previous COVID-19 infection status,
completed the UCLA Loneliness scale (version 3, Russel 1996). This 20-item
scale had participants indicating how often a particular statement was descriptive
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of themselves, with the options being “never,” “rarely,” “sometimes,” or “often,”
with values for each item ranging from 1-4. Scores range from 20-80 and
interpretation is continuous, with no categorical cutoffs. The online survey also
had participants complete several non-diagnostic screening questionnaires to
assess the presence of symptoms common to Autism Spectrum Disorder,
dyslexia, Attention-Deficit Disorder (ADD), depression, and anxiety, as many of
these are commonly comorbid with deficits in attention, memory, and executive
functioning. To measure the expression of Autism-Spectrum traits, the AutismSpectrum Quotient Test was used (Baron-Cohen et al., 2001). Options for each
item were “definitely agree,” “slightly agree,” “slightly disagree,” and definitely
disagree.” In this 50-item, self-administered screening questionnaire for use in
adults within a normal IQ range, the possible scores range from 0-50, with a
score above 26 indicating a higher likelihood of having autism. The “Revised
Dyslexia Checklist” was used to assess symptoms of dyslexia (Vinegard, 1994).
This non-diagnostic screening questionnaire has 20 items that the participant
endorses as true of themselves with a “yes” or a “no.” Scores range from 0-20,
with a score above 8 indicating potential dyslexia or reading difficulties. ADHD
was assessed using the 24-item Jasper-Goldberg Adult ADHD Questionnaire
(Jasper et al., 1993). This non-diagnostic screening questionnaire has individuals
rating 24 items from 0 (“Not at all”) to 5 (“Very much); scores range from 0-120,
with scores over 70 associated with a high likelihood of ADHD. The Beck
Depression Inventory-II (BDI-II) was used to assess symptoms of depression
based on the raw score scale for non-clinical settings (Jackson-Koku, 2016). This
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21-item inventory has 4 different statements for each item, and the participant
endorses whichever of the 4 statements best describes themselves. Each
statement has a score from 0-3; scores range from 0-63, with scores over 21
indicating a high likelihood of clinical depression. The Beck Anxiety Inventory
(BAI) questionnaire was used to assess participants’ level of anxiety (Beck et al.,
1988). This inventory has 21 common symptoms of anxiety, and the participant
rates how often they have been bothered by that particular symptom in the past
month, with scores for each item ranging from 0-3; total scores range from 0-63,
with scores between 22-35 indicating moderate levels of anxiety and scores over
35 indicating “concerning levels of anxiety.” The online portion of the survey,
along with all questions and all options for each question, can be found in
Appendix A.
Stimuli for the in-person portion of the cognitive assessments were
presented on a 23-inch computer monitor. The in-person portion of the
experiment took approximately one hour to complete. Not all participants were
able to complete all cognitive assessments due to occasional time constraints,
but all participants completed at least 7 of the 8 tasks. As previously described,
eight different cognitive assessment tasks were used: Vigilance, Flanker
Compatibility, Digit Span, Berg's Card Sorting Task, Emotional Memory, Match to
Sample, Iowa Gambling Task, and a Change Detection Task. Seven of the
assessments were adapted from existing experiments provided by
Neurobehavioral Systems for use with their Presentation software, and one
assessment (the Change Detection task) was obtained from an outside source
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(see Fukuda and Vogel et al., 2019). Representative stimuli for all cognitive tasks
can be found in Appendix B
Vigilance: Participants were instructed to click the left mouse button when
a white square appeared within the top half of a larger dark navy square in the
middle of the screen and to not take any action if the white square appeared
within the bottom half of the navy square. The vigilance task had 2 blocks, with
one block having more frequently appearing targets than the other block. For the
infrequent block, correct targets appeared on 43 out of the total 193 trials. For the
frequent block, correct targets appeared on 150 of the total 193 trials. There were
20 practice trials before the first block. The target stimuli appeared for 250ms.
Immediately following the display of the target stimuli, the participants had
1750ms to respond using the left mouse button if the target stimuli was in the
upper half of the target area. If the stimuli appeared in the bottom half, the
participants were instructed to not respond. Reaction time, accuracy, number of
missed targets, and the number of false alarms were recorded.
Flanker Compatibility Task: Participants were asked to indicate whether a
square or diamond appeared on the screen within one of four circle outlines
(positioned in the four cardinal directions in relation to the center of the screen).
The shapes could appear in the presence of either zero or three non-target
shapes (crowding shapes) which would also appear within one of the circle
outlines. During some trials, a large distractor shape (always a diamond or
square) would appear to the either the right or left of the 4 circles at the same
time as the target stimuli. Distractor shapes were present on 64 trials, and 64
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trials had no distractor shape. For each trial, the 4 rings would first be displayed
empty for 500ms. After, the rings, target shape, crowding shapes, and distractor
shape (if during a distractor trial) would appear and remain onscreen for 2000ms.
Following this, the participant had 2050ms to respond with either the left mouse
button for a square or the right mouse button for a diamond to indicate which
target shape appeared within the circle outline. Reaction time and error rates
were recorded.
Digit Span: Participants began with the forward-span task. The number
span began at 3 digits. Numbers were presented via a speaker delivered in a
neutral, male voice. Each digit took approximately 500ms to be delivered, and a
500ms pause occurred between each digit delivery. Immediately after the
delivery, participants were asked to type the number string from memory; this
free-response portion was not timed. Once the participant responded with two
correct answers at a given length, the length of the digit span would increase by
one digit until the participant failed both trials for a given digit span length.
Immediately following the forward-span task was the backward-span task, which
proceeded in the same way with the exception that the starting string for the
Backward span began with 2 digits instead of 3. Digit span capacity was
estimated by finding the last list length at which a number string was recalled
correctly.
Berg’s Card Sorting Task: The participant was presented with 4 playing
cards that vary in suit (diamond, triangle, circle, or plus), color (yellow, blue,
green, or red), and number of items on the card (1, 2, 3, or 4). They were then
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given a 5th card to sort into one of the 4 existing card piles. The participant was
not told the criteria to sort by (whether it be suit, color, or number), and
determined through trial and error how to correctly sort the cards. The first sort
was always considered “correct” as long as the card pulled matched at least one
attribute of the sorting pile chosen. The sorting criteria changed after 5 correct
sorts were made in a row; there were 64 total trials. The number of incorrect
sorts following a “rule change” was recorded.
Emotional Memory: This task involves the presentation of words with a
positive (examples: freedom, trust, victory, safe), negative (examples: abuse,
violent, misery, murder), or neutral (examples: wood, circle, corn, board) valence.
Fifteen words of each valence were presented at 1000ms during the encoding
phase as black text upon a white background. After all the words were
presented, participants were then asked to indicate via clicking their mouse
whether a presented word had previously appeared during the experiment.
“Target” words were words that appeared in the initial list of 45 words and were
shown during this recognition phase; “distractor” words were words that were
shown during this recognition phase that did not appear in the initial list of 45
words. Distractor words were also of positive, negative, or neutral valence.
During this recognition phase, words were presented for 5000ms, and
participants had this time and an additional 5000ms to indicate whether they had
previously seen that word or not. The dependent variable for this task is memory
accuracy.
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Match to Sample: A 4x4 grid was presented with squares either shaded in
or unshaded. The number of shaded squares was either 7, 8, or 9. A fixation
point was present for 500ms before the grid was presented. The grid was
presented for 1000ms. After a delay of either 1000ms or 5000ms, two possible
grids were presented: one with the same pattern as before and one with a
different pattern. There was a delay where no objects were on the screen. Then,
participants were asked to select from two different grids which grid was the one
they previously saw. Accuracy and reaction time were measured.
Iowa Gambling Task: Four decks of cards were presented to the
participant. The participant was told in the instructions to draw cards from
whichever deck they want and to attempt to make a “profit.” The trial consisted of
100 trials. Each card drawn tells the participant that they either gained or lost
“money” for that draw. The deck draw for each trial was recorded. If participants
attempted to draw too quickly from a single (i.e., they were not paying attention to
how much money they were gaining or losing), the task ended. The probabilities
for each deck were as follows. Two decks (in this case, Decks 1 and 3) always
yield $100 and two decks (Decks 2 and 4) always yield $50. Ten draws from
Decks 1 or 3 will result in a total loss of $1250, and ten draws from decks 2 and 4
will result in a total loss of $250. This leads to a net loss of $250 for Decks 1 and
3 and a net gain of $250 for Decks 2 and 4. Therefore, Decks 1 and 3 are
considered disadvantageous decks and Decks 2 and 4 are considered
advantageous decks. Deck 3’s loss occurs all at once, with a single $1250
penalty, while Deck 1’s losses occur with penalties ranging from $150-350.
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Similarly, Deck 2’s losses occur with penalties ranging from $25-$75, while Deck
4’s losses occur all at once in the amount of $250. Decks 1 and 3 are both highrisk/high-reward decks, but for different reasons. Deck 3 has a severe but
infrequent risk while Deck 1 has a more consistent risk.
Change Detection Task: 2, 4, 6, or 8 squares of 9 varying, vivid colors
appeared on a light grey background screen for 150ms. After a delay of 900ms
where no squares were present on the screen, a single square appeared on
screen in one of the original locations where a square had appeared previously.
The participant was tasked with determining whether the square was the same
color and in the same position as the previous array of shapes. There were 120
total arrays presented. Accuracy for each of the 4 array sizes was recorded.
2.4 PROCEDURE
Prior to the participant’s appointment for the cognitive assessment, the
participant completed the Google Form portion of the study online. Upon arrival,
the participant was seated in front of the computer and provided with a
description of the nature of the experiment. The participant was instructed to let
the researcher know if they had any questions at any point during the task. The
participant was also made aware that they were allowed to take breaks between
assessments if they desired. Task order was different for each participant and
was determined via an 8-sided die at the time of participation. Participants
completed as many of the 8 tasks as they were willing to; some participants who
arrived late to their appointment did not stay over their allotted time to complete
an 8th task while others chose to fully complete the experiment.
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2.5 HYPOTHESES
It was hypothesized that former COVID-19 infection would have an impact
on cognitive functioning in the following domains: sustained attention, selective
attention, attention shifting, verbal short-term memory, emotionally valence
memory, spatial working memory, and decision making.
It was also hypothesized that increased social isolation (as assessed by
the UCLA Loneliness Scale v3) would have an impact on cognitive functioning in
the same domains mentioned previously. As previously stated, correlations were
calculated to determine whether social isolation scores may be related to any of
the cognitive or self-report measures.
It was also hypothesized that changes in cognitive functioning consistent
with PCC would interact with biological sex. Sex differences and subsequent
cognitive deficits are prevalent in HIV-1 (Rubin et al., 2019; Scully 2018; Qiao et
al., 2019) and Alzheimer’s disease (Laws et al., 2018). However, the sex
differences observed are not consistent across disease or domain. In COVID-19,
more severe symptomology and increased mortality for males has been
observed, in addition to increased cytokines compared to females (Bunders &
Altfeld, 2020; Takahashi et al., 2020). If severity during the acute phase is the
primary determinant of PCC symptoms, it would be expected that biological
males would show more signs of PCC related deficits than females; however,
given that females may have greater neuroinvasiveness and have a higher
prevalence of PCC in general, it may be that prior COVID-19 infection leads to
poorer cognitive outcomes for biological females than biological males

42

2.6 DATA ANALYSIS
Cognitive data were collected from Neurobehavioral Systems’
Presentation software. Survey data were collected using Google Forms. All data
analyses were performed using IBM’s SPSS v20.
First, several correlations were conducted between the measure from a
cognitive assessment and the following: social isolation scores, depression
scores, anxiety scores, ADHD scores, and autism scores. If a correlation with a
significance of p < 0.05 existed between these variables, that factor was added
as a cofactor into the analysis. This was to ensure that all potential covariates
and influencing variables could be accounted for during analysis. It should be
noted that analyses including covariates were also conducted without the
covariates to determine whether there were any discrepancies in the results;
there were no discrepancies found, so covariates remained included in the
relevant analyses to ensure a more accurate portrayal of the results. A full
correlation matrix can be found in Appendix C.
Sex differences were explored for each dependent variable. It should be
assumed that all assumptions were met for all relevant statistical tests unless
otherwise stated. All means have been adjusted to account for any mentioned
covariates, when relevant.
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Table 2.1: Demographic information for the 81 participants who completed both
the online and in-person assessments.

Age (mean, standard deviation)
Biological sex (frequency, percent)
Male
Female
Race (freq., %)
American Indian/Alaskan Native
Asian
Black/African American
White/Caucasian
Unknown/Do not wish to say
Ethnicity (freq., %)
Hispanic or Latino
Non-Hispanic or Latino
Do not wish to say
Vaccine Status (freq., %)
Vaccinated fully
Would prefer not to say
Not vaccinated
Vaccine (freq., %)
Pfizer
Moderna
J&J
Unvaccinated/Unknown/prefer not
to say
Severity (Previously infected only)
“Asymptomatic”
“Mildly infected”
“Evidence of lower respiratory
disease”
Measures (mean, SD)
UCLA Loneliness Scale V3
Beck’s Depression Inventory
Beck’s Anxiety Inventory
Jasper/Goldberg’s Adult ADHD
Self-Test
Baron-Cohen’s Autism Quotient
Vinegrad’s Revised Dyslexia
Checklist

Total
Sample
(n=81)
20.7 (1.6)

COVID-19
Uninfected
(n=35)
21.12 (2.1)

Previously
COVID-19 Infected
(n=46)
20.4 (1.1)

24 (29.6)
57 (70.4)

12
23

12
34

3 (3.7)
10 (12.3)
5 (6.2)
67 (82.7)
4 (4.9)

3
4
4
28
1

0
6
1
39
3

9 (11.1)
71 (87.7)
1 (1.2)

4
31
0

5
40
1

66 (81.5)
3 (3.7)
12 (14.8)

30
0
5

36
3
7

41 (50.6)
19 (23.5)
5 (6.2)
16 (19.8)

15
14
1
5

26
5
4
11

7
37
2

45.1 (10.14)
13.0 (8.80)
19.8 (14.1)
49.3 (27.20)

45.6 (9.84)
11.8 (7.78)
19.9 (15.39)
47.7 (25.42)

44.6 (10.46)
14.0 (9.48)
19.8 (13.16)
50.6 (28.72)

19.8 (6.09)
5.2 (3.9)

19.6 (5.36)
5.74 (3.97)

19.9 (6.65)
4.8 (3.90)

44

CHAPTER 3
RESULTS
3.1 BERG’S CARD SORTING TASK
For the Berg’s Card Sorting task, “average number of sorts until a correct
sort” was used as the dependent variable. This average significantly correlated
with the measure for dyslexia (p=0.004, r=0.319) and autism (p=0.043, r=0.227),
so they were added as covariates into the analysis. One participant was
excluded from the analyses because they did not provide enough information to
accurately calculate their dyslexia and autism scores. There was no significant
difference between those who had previously had COVID-19 (M=2.3831,
SE=0.174) and those who did not (M=2.3642, SE=0.241), F(1,76)=0.126, p =
0.724 (Figure 3.1). However, there was a significant interaction between previous
COVID-19 infection status and biological sex (F(1,74)=4.737, p=0.033, partial eta
squared=0.060), despite biological sex not being significant on its own
(F(1,74)=0.836, p = 0.363) (Figure 3.1).
3.2 DIGIT SPAN TASK
For the Digit Span task, “highest span of digits correctly remembered” was
used as the dependent variable for both the forward-span and backward-span
task. The forward-span number did not significantly correlate with any other preexisting factors, but the backward-span number significantly correlated with
isolation and dyslexia scores, so these two were added as covariates into the
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analysis for the backward-span analysis. Two participants were excluded from
the analyses because they did not provide enough information to accurately
calculate their social isolation and dyslexia scores. A Welch’s t-test was used to
determine whether there were any differences between previously COVID-19
infected (N=46, M=7.087, SE=0.222) and COVID-19 uninfected groups (N=35,
M=6.6857, SE=0.196) on forward digit-span ability; there was no significant
difference Welch’s t(78.981)=1.843, p=0.179) (Figure 3.2A). In the corrected
model, there was no significant effect of COVID-19 infection; there was no
difference between previously COVID-19 infected (N=45, M=5.84, SE=0.198)
and COVID-19 uninfected (N=34, M=5.58, SE=0.321) groups on backward digitspan ability (F(1,75)=0.150, p=0.7) (Figure 3B). There were no significant
interactions between COVID-19 status and sex for either forward (F(1,77)=0.015,
p=0.904) (Figure 3.2A) or backward (F(1,74)=0.017, p=0.896) digit span (Figure
3.2B). The significant correlation between backward digit span ability and social
isolation prompted analysis via linear regression. The regression equation
including social isolation and dyslexia scores was significant, F(2,76)=4.535,
R2=0.107, p=0.014, but the overall contribution of social isolation scores to the
model was minimal (F-change significance= 0.240), and added only 0.017 to R2.
(Figure 3.2C)
3.3 CHANGE DETECTION TASK
For the Change Detection task, short-term memory capacity was
estimated using the accuracy rates from the 2, 4, 6, and 8 set sizes as previously
described (Cowan, 2001). This estimated short-term memory capacity
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significantly correlated with the measure for dyslexia (p=0.044; r = -0.227), so
dyslexia was added as a covariate into the analyses. One participant was
excluded from the analyses because they did not provide enough information to
calculate their dyslexia scores; one participant was excluded because they did
not complete the task. There was no significant difference between those who
had previously had COVID-19 (N=44, M=3.841, SE=0.070) and those who did
not (N=35, M=3.735, SE=0.078), F(1, 76)=1.014, p=0.317 (Figure 3.3). There
was also no significant interaction between biological sex and COVID-19
infection status (F(1,74)=0.679, p=0.414) (Figure 3.3).
3.4 EMOTIONAL MEMORY TASK
For the Emotional Memory task, accuracy for remembered words was
obtained for positive, negative, neutral, and distractor words. Average accuracy
for positive, negative, neutral, or distractor words was not significantly different
between COVID-19 uninfected and previously COVID-19 infected groups. One
participant was excluded from the analyses because they did not complete the
task. For positively valanced words, there was no significant difference of
accuracy between COVID-19 uninfected (N=35, M=0.743, SE=0.026) and
previously COVID-19 infected (N=45, M=0.726, SE=0.029) groups (t(78)=-0.418,
p=0.677) (Figure 3.4A). For negatively valanced words, there was no significant
difference of accuracy between COVID-19 uninfected (N=35, M=0.76, SE=0.029)
and previously COVID-19 infected (N=45, M=0.776, SE=0.024) groups
(t(78)=0.432, p=0.667) (Figure 3.4B). For neutral words, there was no significant
difference of accuracy between COVID-19 uninfected (N=35, M=0.73, SE=0.028)
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and previously COVID-19 infected (N=45, M=0.708, SE=0.027) groups (t(78)=0.54, p=0.591) (Figure 3.4C). For distractor words, there was no significant
difference of accuracy between COVID-19 uninfected (N=35, M=0.789, SE=0.03)
and previously COVID-19 infected (N=45, M=0.782, SE=0.022) groups (t(78)=0.192, p=0.848) (Figure 3.4D). A significant interaction between COVID-19
infection status and biological sex was found only for distractor word accuracy
(F(1,76)=4.992, p=0.028, partial eta squared=0.062) (Figure 3.4D). There was no
significant difference between COVID-19 uninfected (N=35, M=0.751, SE=0.025)
and previously COVID-19 infected (N=45, M=0.7511, SE=0.024) groups on
accuracy for emotional words (t(78)=-0.008, p=0.994) (Figure 3.4E). There was
no significant difference between COVID-19 uninfected (N=35, M=0.759,
SE=0.023) and previously COVID-19 infected (N=45, M=0.75, SE=0.019) groups
on accuracy for non-emotional words (t(78)=-0.484, p=0.63) (Figure 3.4F). There
was no significant interaction between COVID-19 infection status and biological
sex on accuracy for emotional words (F(1,76)=0.199, p=0.657; Figure 3.4E) or
non-emotional words (F(1,76)=1.122, p=0.293; Figure 3.4F). It should be noted
that the total sample reflected the expected difference in accuracy for emotional
(M=0.74, SE=0.01621) words versus non-emotional (M=0.7174, SE= 0.1953)
words (Paired sample t test: t(79)=2.049, p=0.044); in addition, negative
(M=0.7692, SE=0.0186) words were remembered significantly more than positive
(M=0.7333, SE=0.0198) words (Paired sample t test: t(79)=2.061, p=0.043).
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3.5 VIGILANCE TASK
For the Vigilance task, overall accuracy, number of false alarms, number
of misses, and an accuracy comparison between the first and second block were
the dependent variables analyzed. Five participants were excluded from the
analyses because they did not complete the task. For overall accuracy, there
was no significant difference between previously COVID-19 infected (N=45,
M=0.991, SE=0.003) and COVID-19 uninfected (N=32, M=0.981, SE=0.007)
groups (Welch’s t=1.746, p=0.194) (Figure 3.5A). A 2-way ANOVA for overall
accuracy between biological sex and COVID-19 infection status could not be
reliably conducted due to the violation of homogeneity of variance (Levene’s
F=8.105, p<0.001), but regardless there was no significant interaction (F (1,
72)=3.578, p=0.063) (Figure 3.5A). For total number of false alarms, there was
no significant difference between previously COVID-19 infected (N=45, M=4.4,
SE=0.665) and COVID-19 uninfected (N=32, M=3.72, SE=0.514) groups
(t(75)=0.757, p=0.452) (Figure 3.5B). There was no significant interaction
between COVID-19 infection status and biological sex on total number of false
alarms (F(1,73)=0.001, p=0.979) (Figure 3.5B). For total number of misses, there
was no significant difference between previously COVID-19 infected (N=45,
M=1.49, SE=0.478 and COVID-19 uninfected (N=32, M=3.41, SE=1.126) groups
(Welch’s t=2.456, p=0.125) (Figure 3.5C). A 2-way ANOVA between biological
sex and COVID-19 infection status for total number of misses could not be
reliably conducted due to the violation of homogeneity of variance (Levene’s
F=7.846, p<0.001), but regardless there was no significant interaction (F(1,
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72)=3.461, p=0.067) (Figure 3.5C). The accuracy comparison value reflects the
overall accuracy on the first half of the task minus the accuracy on the second
half; in other words, negative values indicate an increase in performance in the
second half of the task. For the accuracy comparison value, there was no
significant difference between previously COVID-19 infected (N=45, M=-0.006,
SE=0.004) and COVID-19 uninfected (N=32, M=-0.005, SE=0.007) groups
(t(75)=-0.09, p=0.928) (Figure 3.5D). There was no significant interaction
between COVID-19 infection status and biological sex on this accuracy
comparison value (F(1,73)=0.606, p=0.439) (Figure 3.5D).
3.6 IOWA GAMBLING TASK
For the Iowa Gambling task, four dependent variables were examined.
Twenty-three participants were excluded from the analyses because they either
did not complete the task, or the paradigm detected that they were too quickly
choosing from one deck repeatedly (thus not taking the time to consider their
choices and see the consequences before choosing again). First, the proportion
of high-risk-high-reward choices within the last half (draws from Deck 3 in the last
50 draws) of the task was calculated. For the high-risk-high-reward variable,
there was no significant difference between previously COVID-19 infected (N=33,
M=0.345, SE=0.03) and COVID-19 uninfected (N=25, M=0.375, SE=0.03) groups
(t(56)=-0.699, p=0.488) (Figure 3.6A). There was no significant interaction
between biological sex and COVID-19 infection status for the high-risk-highreward variable (F(1,54)=0.001, p=0.970) (Figure 3.6A).
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Second, the proportion of frequent-risk-high-reward choices within the last
half (draws from Deck 1 in the last 50 draws) of the task was calculated. For the
frequent-risk-high-reward variable, there was no significant difference between
previously COVID-19 infected (N=33, M=0.1515, SE=0.015) and COVID-19
uninfected (N=25, M=0.1688, SE=0.016) groups (t(56)=-0.771, p=0.444) (Figure
3.6B). There was no significant interaction between biological sex and COVID-19
infection status for the high-risk-high-reward variable (F(1,54)=0.091, p=0.764)
(Figure 3.6B).
Third, the proportion of disadvantage draws within the last half of the task
was calculated. For the “proportion of disadvantageous draws in the last half”
variable, there was significant correlation with isolation scores (r = -0.273,
p=0.038), so that variable was added as a covariate; there was no significant
difference between previously COVID-19 infected (N=33, M=0.498, SE=0.026)
and COVID-19 uninfected (N=25, M=0.542, SD=0.030) groups (F(1,55)=1.264,
p=0.266 (Figure 3.6C). The significant correlation with social isolation scores
prompted a separate analysis. Using linear regression, social isolation scores
were a significant (p=0.038) predictor of “proportion of disadvantageous draws in
the last half of the task” (r=0.273), such that: % disadvantageous draws in the
last half= 0.701 + (-0.004*social isolation score). (Figure 3.6D). There was no
significant interaction between biological sex and COVID-19 infection status on
“proportion of disadvantageous draws in the last half” (F(1,53)=0.007, p=0.936)
(Figure 3.6C).
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The fourth dependent variable was a proportion of the disadvantaged
draws from the first half of the task to the last half of the task; values over 1
indicate that more disadvantageous choices were made earlier in the task than
later in the task. For the “disadvantageous draws early vs late” variable, there
was no significant difference between previously COVID-19 infected (N=33,
M=1.375, SE=.255) and COVID-19 uninfected (N=25, M=1.11, SD=0.109)
groups (t(56)=0.848, p=0.400) (Figure 3.6E). There was also no significant
interaction between biological sex and COVID-19 infection status on
“disadvantageous draws early vs late” (F(1,54)=0.938, p=0.337) (Figure 3.6E).
3.7 MATCH TO SAMPLE
For the Match to Sample task, 5-second-delay accuracy, 5-second-delay
reaction time, 1-second-delay accuracy, and 1-second-delay reaction time were
evaluated as dependent variables. Both 5-second and 1-second accuracy
significantly correlated with the measure for dyslexia (p<0.002; r’s = -0.365 and 0.520, respectively); dyslexia was added as a covariate into the analyses. One
participant was excluded from the analyses because they did not provide enough
data to accurately calculate their dyslexia score; one participate was excluded
from the analyses because they did not complete this task. For the 5-second
delay accuracy, there was no significant difference between those who had
previously had COVID-19 (N=45, M=0.872, SE=0.017) and those who did not
(N=34, M=0.864, SE=0.02), F(1, 76)=0.094, p=0.759 (Figure 3.7A). There was
also no significant interaction between biological sex and COVID-19 infection
status on 5-second delay accuracy (F(1,74)=0.002, p=0.961) (Figure 3.7A). For
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the 5-second delay reaction time, there was no significant difference between
those who had previously had COVID-19 (N=46, M=1499.760, SE=56.049) and
those who did not (N=34, M=1417.3259, SE=49.224), Welch’s t=1.221, p=0.273
(Figure 3.7B). There was also no significant interaction between biological sex
and COVID-19 infection status on 5-second delay reaction time (F(1,76)=0.441,
p=0.508) (Figure 3.7B). For the 1-second delay accuracy, there was no
significant difference between those who had previously had COVID-19 (N=45,
M=0.907, SE=0.013) and those who did not (N=34, M=0.920, SE=0.015), F(1,
76)=0.434, p=0.512 (Figure 3.7C). There was also no significant interaction
between biological sex and COVID-19 infection status on 1-second delay
accuracy (F(1,74)=0.032, p=0.859) (Figure 3.7C). For the 1-second delay
reaction time, there was no significant difference between those who had
previously had COVID-19 (N=46, M=1305.646, SE=51.774) and those who did
not (N=34, M=1221.780, SE=40.795), t(78)=-1.203, p=0.233 (Figure 3.7D). There
was also no significant interaction between biological sex and COVID-19
infection status on 1-second delay reaction time (F(1,76)=0.623, p=0.433)
(Figure 3.7D).
3.8 FLANKER TASK
For the Flanker task, a comparison value was calculated to determine to
change in reaction time and accuracy between a compatible and incompatible
distractor shape trials. This was calculated by subtracting the incompatible from
the compatible trials; positive values represent that the participant was more
accurate (or quicker, for the reaction time assessment) on the compatible trials
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than on the incompatible trials. One participant was excluded from the analyses
because they did not complete the task; two participants were excluded because
they did not provide enough information to accurately calculate their dyslexia and
anxiety scores. The comparison accuracy value correlated significantly with both
dyslexia (r = -0.291, p=0.039) and anxiety (r = -0.32, p=0.004), so these were
added as covariates into relevant analyses. There was no significant difference
between those who had previously had COVID-19 (N=44, M=0.018, SE=0.012)
and those who did not (N=34, M=0.018, SE=0.013), F(1, 74)=0.001, p=0.979
(Figure 3.8A); there was also no significant interaction between COVID-19
infection status and biological sex (F(1,72)=0.153, p=0.697) (Figure 3.8A). For
the comparison reaction time value, there was no significant difference between
those who had previously had COVID-19 (N=46, M=-40.438, SE=9.477) and
those who did not (N=34, M=-55.561, SE=11.391), t(78)=1.093, p=0.278 (Figure
3.8B); there was also no significant interaction between COVID-19 infection
status and biological sex (F(1,76)=0.660, p=0.419) (Figure 3.8B).
3.9 CONSTRUCT VALIDITY OF COGNITIVE MEASURES
To evaluate the validity of our measures for the cognitive constructs of
interest (attention, working memory, cognitive flexibility, and decision making) we
performed an exploratory factor analysis using variables from our cognitive tasks.
The analysis was conducted using the JASP software package (JASP 2022,
Macintosh version 0.16.3). Bartlett’s test of sphericity (Bartlett, 1950) was used to
ensure that the correlation matrix was not random and the KMO statistic (Kaiser,
1974) was required to be above a minimum of .60. Common factor analysis was
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performed using a minimum residual estimation procedure with oblique rotation
(promax). Parallel analysis and visual scree analysis were used to determine the
number of factors to be retained. It should be noted that this study was not
designed with the purpose of performing factor analysis. Although the correlation
matrix was determined to meet the minimum standards for factor analysis
[Bartlett’s test of sphericity - χ2(171)= 1037, p < .001 ; KMO statistic= 0.64, which
is considered “mediocre”] it was not ideally suited to this analysis. Coupled with
the low number of participants, the results of this analysis should be interpreted
with caution.
With that in mind, the cognitive tasks used did generally cluster into
factors that were in line with our hypothesized cognitive constructs. Parallel
analysis and visual scree plots both suggested that four factors should be
retained. As can be seen in Table 3.1, Factor 1 consisted of memory-related
response time measures, while Factor 2 consisted of memory-related accuracy
measures. The measures from the vigilance task loaded on Factor 3, while the
measures from the Flanker task loaded on Factor 4. The separation of the two
attention tasks onto different factors is consistent with the idea that the Vigilance
Task and Flanker Task assess different aspects of attention (sustained vs.
selective attention, respectively).
Interestingly, although we conceptualized the Berg Card Sorting Task as a
measure of cognitive flexibility, the number of sorts on the BCST had a negative
loading on Factor 2 (memory accuracy), which is in line with the idea that card
sorting tasks depend on working memory for processes like set maintenance and
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rule inference (e.g., Lange et al., 2016; Lehto, 1996), with poorer working
memory capacity leading to more sorts before rule learning. It is also possible
that if our study included additional measures of cognitive flexibility a separate
factor that included the BCST would have emerged.
The proportion of disadvantageous draws on the Iowa Gambling Task, our
measure for decision making, was not included the final factor analysis because
of the high proportion of missing data (58 participants included, compared to 7681 for the other tasks). However, when included in the model IGT performance
did not load on any of the factors (uniqueness= .917) and did not change the
parcellation of the other tasks onto the four factors, suggesting that the IGT was
measuring distinct cognitive processes from our other tasks.
3.10 OTHER FINDINGS
It was found that social isolation correlated significantly with number of
symptoms endorsed for depression (r =0.495, p<0.001) (Figure 3.9A), dyslexia (r
=0.361, p=0.001) (Figure 3.9B), ADHD (r =0.359, p=0.001) (Figure 3.9C), and
autism spectrum disorder (r =0.571, p<0.001) (Figure 3.9D). “Days since COVID19 infection” (Mean= 303.98, minimum= 20, maximum=639) correlated
significantly with the number of symptoms endorsed for dyslexia (r = -0.380,
p=0.008) (Figure 3.10A) and social isolation scores (r = -0.298, p=0.038) (Figure
3.10B).
On the Google Form survey, participants were asked “If you experienced
social isolation during COVID-19, do you personally think that it has had lasting
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effects on your mental wellbeing (i.e., has it heightened any depression, anxiety,
etc.)?” and “If you experienced social isolation during COVID-19, do you
personally think that it has had lasting effects on your mental abilities (attention
span, memory, cognition)?” The potential options were: “Yes, and I think these
effects will last for a long time,” “Yes, but I think these effects will not last for very
long,” “No, my mental wellbeing/abilities has/have remained the same,” “No, and
my mental wellbeing/abilities is/are better than it/they were before quarantine,”
and “I did not experience social isolation during COVID-19.”
The “effect on mental wellbeing” groups were significantly different in
number of symptoms reported for anxiety (F(4,79)=2.821, p=0.03) (Figure
3.11A), depression (F(4,80)=6.506, p<0.001) (Figure 3.11B), and ADHD
(F(4,80)=3.81, p=0.007) (Figure 3.11C). The “effect on mental abilities” groups
were significantly different in number of symptoms reported for depression
(F(4,80)=6.078, p<0.001) (Figure 3.12A), dyslexia (F(4,80)=3.049, p=0.022)
(Figure 3.12B), and ADHD (F(4,80)=3.504, p=0.011) (Figure 3.12C).
Frequency data for how the pandemic has affected participants’ mental
wellbeing (Figure 3.13A) and how the pandemic has affected participants’ mental
abilities (Figure 3.13B) were also collected. Quarantining habits were assessed
by totaling the number of activities that an individual was willing to do during a
certain timeframe of the pandemic (Figure 3.14). Frequency data for sense loss
of taste and smell were also collected for previously infected participants, where
fairly equal numbers of participants either lost or did not lose their sense of taste
or small, but very few showed ongoing deficits (Figure 3.15).
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For the psychiatric questionnaires, previously infected and never infected
groups were not significantly different on raw score as assessed by independent
samples T-test for Beck’s Anxiety Inventory (t(77)= 0.035, p=0.972), UCLA Social
Isolation (t(79)= 0.446, p=0.657), Beck’s Depression Inventory (t(78)= -1.126,
p=0.264), Adult Dyslexia Checklist (t(78)= 1.09, p=0.279), Adult ADHD Self-Test
(t(78)= -0.46, p=0.647), and the Autism Spectrum Quotient Test (t(78)= -0.209,
p=0.835) (means found in Table 2.1). The proportion of participants in each
group who met the score cutoff for moderate levels of anxiety was not
significantly different between groups (previously infected= 37.78%, uninfected=
37.14%, X2(1, N=79)= 0.018, p= 0.892); there was also no significant different in
proportions for high anxiety (previously infected= 24.44%, uninfected= 14.29%,
X2(1, N=79)= 1.143, p= 0.285). The proportion of participants in each group who
met the score cutoff for “high likelihood of clinical depression” was not
significantly different between groups (previously infected= 24.44%, uninfected=
14.29%, X2(1, N=80)= 1.27, p= 0.260). The proportion of participants in each
group who met the score cutoff for “high likelihood of dyslexia” was not
significantly different between groups (previously infected= 17.78%, uninfected=
28.56%, X2(1, N=80)= 1.315, p= 0.251). The proportion of participants in each
group who met the score cutoff for “high probability of ADHD” was not
significantly different between groups (previously infected= 26.67%, uninfected=
20%, X2(1, N=80)= 0.483, p= 0.487). The proportion of participants in each group
who met the score cutoff for a “high likelihood of having autism” was not
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significantly different between groups (previously infected= 17.77%, uninfected=
5.71%, X2(1, N=80)= 2.620, p= 0.106).
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Table 3.1 - Factor Loadings
Factor 1 F2
F3
F4 Uniqueness
Match to Sample: 1 sec. RT
0.648 0.232 0.118 0.291
0.460
Match to Sample: 5 sec. RT
0.573 0.275 0.211 0.429
0.388
Emotional Memory: Neg. RT
0.943 0.079 -0.024 -0.128
0.200
Emotional Memory: Neut. RT
0.899 -0.131 -0.052 -0.230
0.152
Emotional Memory: Pos. RT
0.837 -0.145 0.007 -0.136
0.240
Match to Sample: 1 sec. Acc.
-0.170 0.597 -0.102 0.231
0.549
Match to Sample: 5 sec. Acc.
0.239 0.771 -0.149 -0.112
0.415
Emotional Memory: Neg. Acc.
-0.339 0.407 0.227 -0.092
0.541
Emotional Memory: Neut. Acc.
-0.132 0.389 0.190 -0.092
*0.739
Emotional Memory: Pos. Acc.
-0.145 0.404 0.108 -0.253
0.648
Forward Digit Span
-0.158 0.312 -0.067 0.031
*0.842
Backward Digit Span
0.090 0.680 -0.116 0.115
0.566
Memory Capacity Estimate
-0.006 0.682 -0.120 -0.054
0.493
BCST Sorts
-0.188 -0.560 -0.013 0.184
0.673
Vigilance: Hits
0.060 0.069 -0.841 -0.146
0.244
Vigilance: Misses
-0.053 -0.091 0.995 0.054
-0.015
Vigilance: False alarms
0.138 -0.153 0.499 -0.065
0.696
Flanker: Incompatible RT
-0.125 -0.139 0.073 0.822
0.297
Flanker: Compatible RT
-0.096 -0.096 -0.007 0.918
0.158
Note. Applied rotation method is promax. Factor loadings that did not meet the
0.4 salience threshold are greyed out. Variables marked with a * were high on
Uniqueness and only had a salient factor loading when the threshold was
reduced to 0.3.
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Figure 3.1: Berg’s Card Sorting Task. Mean number of sorts until a correct sort
for previously COVID-19 infected (N= 45, adjusted M= 2.3831, SE= 0.174),
COVID-19 uninfected (N= 35, adj. M= 2.3642 , SE= 0.241), COVID-19 uninfected
males (N= 12, adj. M= 1.67 , SE= 0.113), previously COVID-19 infected males
(N= 11, adjusted M= 2.4995, SE= 0.366), previously COVID-19 infected females
(N= 34, adj. M= 2.3455, SE= 0.2), and COVID-19 uninfected females (N= 23, adj.
M= 2.7264 , SE= 0.34).
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Figure 3.2: Digit Span Task. A) Mean number of digits remembered in the
Forward Digit Span Task for previously COVID-19 infected (N= 46, M= 7.087,
SE= 0.222), COVID-19 uninfected (N= 35, M= 6.686, SE= 0.196), previously
COVID-19 infected males (N= 12, M= 7.5, SE= 0.571), COVID-19 uninfected
males (N= 12, M= 7 , SE= 0.408), previously COVID-19 infected females (N= 34,
M= 6.9412, SE= 0.223), and COVID-19 uninfected females (N= 23, M= 6.5217 ,
SE= 0.207). B) Mean number of digits remembered in the Backward Digit Span
Task for previously COVID-19 infected (N= 45, adjusted M= 5.8444, SE= 0.198),
COVID-19 uninfected (N= 34, adj. M= 5.5882 , SE= 0.322), previously COVID-19
infected males (N= 11, adjusted M= 6.4545, SE= 5, COVID-19 uninfected males
(N= 11, adj. M= 6 , SE= 0.523), previously COVID-19 infected females (N= 34,
adj. M= 5.647, SE= 0.211), and COVID-19 uninfected females (N= 23, adj. M=
5.391 , SE= 0.406). C) A scatterplot of social isolation scores plotted against the
adjusted predicted values for backward digit span memory length.
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Figure 3.3: Change Detection Task. Mean estimated short-term memory
capacity for previously COVID-19 infected (N= 44, adjusted M= 3.841, SE= 0.07),
COVID-19 uninfected (N= 35, adj. M= 3.735 , SE= 0.078), previously COVID-19
infected males (N= 11, adjusted M= 3.777, SE= 0.143), COVID-19 uninfected
males (N= 12, adj. M= 3.805 , SE= 0.135), previously COVID-19 infected females
(N= 33, adj. M= 3.862, SE= 0.081), and COVID-19 uninfected females (N= 23,
adj. M= 3.699 , SE= 0.098).
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Figure 3.4: The Emotional Memory Task. A) Mean accuracy for positively
valenced words for previously COVID-19 infected (N= 45, M= 0.726, SE=
0.02884), COVID-19 uninfected (N= 35, M= 0.7428 , SE= 0.02652), previously
COVID-19 infected males (N= 12, M= 0.789, SE= 0.051), COVID-19 uninfected
males (N= 12, M= 0.744 , SE= 0.051), previously COVID-19 infected females
(N= 33, M= 0.703, SE= 0.031), and COVID-19 uninfected females (N= 23, M=
0.742 , SE= 0.037). B) Mean accuracy for negatively valenced words for
previously COVID-19 infected (N= 45, M= 0.7763, SE= 0.02417), COVID-19
uninfected (N= 35, M= 0.76 , SE= 0.02933), previously COVID-19 infected males
(N= 12, M= 0.8278, SE= 0.048), COVID-19 uninfected males (N= 12, M= 0.8167
, SE= 0.048), previously COVID-19 infected females (N= 33, M= 0.7576, SE=
0.029), and COVID-19 uninfected females (N= 23, M= 0.7304 , SE= 0.034). C)
Mean accuracy for neutrally valenced words for previously COVID-19 infected
(N= 45, M= 0.7081, SE= 0.02699), COVID-19 uninfected (N= 35, M= 0.7295 ,
SE= 0.02838), previously COVID-19 infected males (N= 12, M= 0.7777, SE=
0.05), COVID-19 uninfected males (N= 12, M= 0.7666 , SE= 0.03), previously
COVID-19 infected females (N= 33, M= 0.6828, SE= 0.03), and COVID-19
uninfected females (N= 23, M= 0.7101 , SE= 0.036). D) Mean accuracy for
distractor words for previously COVID-19 infected (N= 45, M= 0.7817, SE=
0.02181, COVID-19 uninfected (N= 35, M= 0.7886 , SE= 0.02978), previously
COVID-19 infected males (N= 12, M= 0.7518, SE= 0.045), COVID-19 uninfected
males (N= 12, M= 0.8741 , SE= 0.045), previously COVID-19 infected females
(N= 33, M= 0.7925, SE= 0.027), and COVID-19 uninfected females (N= 23, M=
0.744 , SE= 0.033).
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Figure 3.4 (continued): The Emotional Memory Task. E) Mean accuracy of
emotional words for previously COVID-19 infected (N= 45, mean= 0.7511, SE=
0.02387), COVID-19 uninfected (N= 35, mean= 0.7514 , SE= 0.0248), previously
COVID-19 infected males (N= 12, mean= 0.8083, SE= 0.044), COVID-19
uninfected males (N= 12, mean= 0.7805 , SE= 0.044), previously COVID-19
infected females (N= 33, mean= 0.7303, SE= 0.027), and COVID-19 uninfected
females (N= 23, mean= 0.7362 , SE= 0.032). F) Mean accuracy of non-emotional
words for previously COVID-19 infected (N= 45, mean= 0.7449, SE= 0.0186),
COVID-19 uninfected (N= 35, mean= 0.759 , SE= 0.02287), previously COVID19 infected males (N= 12, mean= 0.765, SE= 0.037), COVID-19 uninfected
males (N= 12, mean= 0.82 , SE= 0.037), previously COVID-19 infected females
(N= 33, mean= 0.738, SE= 0.022), and COVID-19 uninfected females (N= 23,
mean= 0.727 , SE= 0.027).
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Figure 3.5: Vigilance Task. A) Mean accuracy for previously COVID-19 infected
(N= 45, mean= 0.99061, SE= 0.002637), COVID-19 uninfected (N= 32, mean=
0.98087 , SE= 0.006887), previously COVID-19 infected males (N= 11, mean=
0.989, SE= 0.008), COVID-19 uninfected males (N= 10, mean= 0.961 , SE=
0.009), previously COVID-19 infected females (N= 34, mean= 0.991, SE= 0.005),
and COVID-19 uninfected females (N= 22, mean= 0.99 , SE= 0.006). B) Mean
number of false alarms for previously COVID-19 infected (N= 45, mean= 4.4,
SE= 0.665), COVID-19 uninfected (N= 32, mean= 3.72 , SE= 0.514), previously
COVID-19 infected males (N= 11, mean= 4.091, SE= 1.189), COVID-19
uninfected males (N= 10, mean= 3.4 , SE= 1.247), previously COVID-19 infected
females (N= 34, mean= 4.5, SE= 0.676), and COVID-19 uninfected females (N=
22, mean= 3.864 , SE= 0.84). C) Mean number of misses for previously COVID19 infected (N= 45, mean= 1.49, SE= 0.478), COVID-19 uninfected (N= 32,
mean= 3.41 , SE= 1.126), previously COVID-19 infected males (N= 11, mean=
1.182, SE= 1.406), COVID-19 uninfected males (N= 10, mean= 6.3 , SE= 1.475),
previously COVID-19 infected females (N= 34, mean= 1.588, SE= 0.8), and
COVID-19 uninfected females (N= 22, mean= 2.091 , SE= 0.994). D) Mean
accuracy comparison (accuracy on the first half of the task minus accuracy on
the last half of the task) for previously COVID-19 infected (N= 45, mean= 0.0060327, SE= 0.0037875), COVID-19 uninfected (N= 32, mean= -0.005344 ,
SE= 0.00735559), previously COVID-19 infected males (N= 11, mean= -0.017,
SE= 0.01), COVID-19 uninfected males (N= 10, mean= -0.024 , SE= 0.01),
previously COVID-19 infected females (N= 34, mean= -0.003, SE= 0.006), and
COVID-19 uninfected females (N= 22, mean= 0.003 , SE= 0.007).
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Figure 3.6: Iowa Gambling Task. A) Mean proportion of high-risk/high-reward
choices that occurred during the last half of the Iowa Gambling Task for
previously COVID-19 infected (N= 33, mean= 0.34485, SE= 0.030339), COVID19 uninfected (N= 25, mean= 0.3752 , SE= 0.029738), previously COVID-19
infected males (N= 8, mean= 0.29, SE= 0.058), COVID-19 uninfected males (N=
7, mean= 0.326 , SE= 0.062), previously COVID-19 infected females (N= 25,
mean= 0.362, SE= 0.033), and COVID-19 uninfected females (N= 18, mean=
0.394 , SE= 0.039). B) Mean proportion of frequent-risk/high-reward choices that
occurred during the last half of the Iowa Gambling Task for previously COVID-19
infected (N= 33, mean= 0.1515, SE= 0.015), COVID-19 uninfected (N= 25,
mean= 0.1688 , SE= 0.016), previously COVID-19 infected males (N= 8, mean=
0.1575, SE= 0.03), COVID-19 uninfected males (N= 7, mean= 0.1857 , SE=
0.032), previously COVID-19 infected females (N= 25, mean= 0.1496, SE=
0.017), and COVID-19 uninfected females (N= 18, mean= 0.1622 , SE= 0.02). C)
Mean proportion of disadvantageous draws within the last half of the Iowa
Gambling Task for previously COVID-19 infected (N= 33, adjusted mean= 0.498,
SE= 0.026), COVID-19 uninfected (N= 25, adj. mean= 0.542 , SE= 0.03),
previously COVID-19 infected males (N= 8, adjusted mean= 0.459, SE= 0.053),
COVID-19 uninfected males (N= 7, adj. mean= 0.51 , SE= 0.056), previously
COVID-19 infected females (N= 25, adj. mean= 0.51, SE= 0.03), and COVID-19
uninfected females (N= 18, adj. mean= 0.555 , SE= 0.035).
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Figure 3.6 (continued): Iowa Gambling Task. D) Scatterplot displaying social
isolation scores plotted against the proportion of disadvantageous draws during
the last half of the task. E) Mean proportion of disadvantageous draws between
the first and last half of the Iowa Gambling Task for previously COVID-19
infected (N= 33, mean= 1.375308, SE= 0.2551396), COVID-19 uninfected (N=
25, mean= 1.113376 , SE= 0.1093428), previously COVID-19 infected males (N=
8, mean= 2.099, SE= 0.402), COVID-19 uninfected males (N= 7, mean= 1.322 ,
SE= 0.43), previously COVID-19 infected females (N= 25, mean= 1.144, SE=
0.228), and COVID-19 uninfected females (N= 18, mean= 1.032 , SE= 0.268).
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Figure 3.7: Match to Sample Task. A) Mean accuracy of the 5-second delay
task for previously COVID-19 infected (N= 45, adjusted mean= 0.872, SE=
0.017), COVID-19 uninfected (N= 34, adj. mean= 0.864 , SE= 0.02), previously
COVID-19 infected males (N= 11, adjusted mean= 0.879, SE= 0.035), COVID-19
uninfected males (N= 12, adj. mean= 0.871 , SE= 0.033), previously COVID-19
infected females (N= 34, adj. mean= 0.871, SE= 0.02), and COVID-19 uninfected
females (N= 22, adj. mean= 0.86 , SE= 0.025). B) Mean reaction time for the 5second delay task for previously COVID-19 infected (N= 46, mean= 1499.7598,
SE= 56.04943), COVID-19 uninfected (N= 34, mean= 1417.3259 , SE= 49.2247),
previously COVID-19 infected males (N= 12, mean= 1523.307, SE= 100.225),
COVID-19 uninfected males (N= 12, mean= 1364.592 , SE= 100.225), previously
COVID-19 infected females (N= 34, mean= 1491.449, SE= 59.543), and COVID19 uninfected females (N= 22, mean= 1446.09 , SE= 74.021). C) Mean accuracy
of the 1-second delay task for previously COVID-19 infected (N= 45, adjusted
mean= 0.907, SE= 0.013), COVID-19 uninfected (N= 34, adj. mean= 0.92 , SE=
0.015), previously COVID-19 infected males (N= 11, adjusted mean= 0.939, SE=
0.026), COVID-19 uninfected males (N= 12, adj. mean= 0.942 , SE= 0.025),
previously COVID-19 infected females (N= 34, adj. mean= 0.897, SE= 0.015),
and COVID-19 uninfected females (N= 22, adj. mean= 0.908 , SE= 0.018). D)
Mean reaction time for the 1-second delay task for previously COVID-19 infected
(N= 46, mean= 1305.6461, SE= 51.73375), COVID-19 uninfected (N= 34, mean=
1221.7803 , SE= 40.79546), previously COVID-19 infected males (N= 12, mean=
1357.512, SE= 89.737), COVID-19 uninfected males (N= 12, mean= 1189.188 ,
SE= 89.737), previously COVID-19 infected females (N= 34, mean= 1287.34,
SE= 53.312), and COVID-19 uninfected females (N= 22, mean= 1239.558 , SE=
66.275).
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Figure 3.8: The Flanker Task. A) Mean accuracy of compatible trials minus
incompatible trials during the Flanker Task for previously COVID-19 infected (N=
44, adjusted mean= 0.018, SE= 0.012), COVID-19 uninfected (N= 34, adj.
mean= 0.018 , SE= 0.013), previously COVID-19 infected males (N= 11,
adjusted mean= 0.021, SE= 0.025), COVID-19 uninfected males (N= 12, adj.
mean= 0.01 , SE= 0.024), previously COVID-19 infected females (N= 33, adj.
mean= 0.017, SE= 0.014), and COVID-19 uninfected females (N= 22, adj.
mean= 0.022 , SE= 0.017). B) Mean reaction time of compatible trials minus
incompatible trials during the Flanker Task for previously COVID-19 infected (N=
46, mean= -40.4378, SE= 9.47743), COVID-19 uninfected (N= 34, mean= 56.5608 , SE= 11.3914), previously COVID-19 infected males (N= 12, mean= 48.953, SE= 18.984), COVID-19 uninfected males (N= 12, mean= -47.024 , SE=
18.984), previously COVID-19 infected females (N= 34, mean= -37.433, SE=
11.278), and COVID-19 uninfected females (N= 22, mean= -61.763 , SE= 14.02).
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Figure 3.9: Scatterplots for Social Isolation scores. A) Social isolation scores
plotted against Beck’s Depression Inventory scores (N= 87, r = 0.495, p<0.001).
B) Social isolation scores plotted against Dyslexia Checklist scores (N= 87, r
=0.361, p=0.001). C) Social isolation scores plotted against Adult ADHD SelfTest scores (N= 87, r =0.359, p=0.001). D) Social isolation scores plotted against
Autism Quotient (N= 87, r =0.571, p<0.001).
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Figure 3.10: Scatterplots for “Days Since Having COVID-19.” A) Days since
having COVID-19 plotted against Dyslexia Checklist scores (N= 48, r =-0.380,
p=0.008). B) Days since having COVID-19 plotted against Social Isolation scores
(N= 49, r =-0.298, p=0.038).
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Figure 3.11: Effect on Mental Wellbeing. A) Mean Beck’s Anxiety Inventory Score
for participants who believe that the social isolation they experienced will have
effects on their mental wellbeing that will last for a long time (Overall: N= 30,
mean= 25.56, SE= 2.72; Previously infected: N= 17, mean= 29.0588, SE= 3.286;
Uninfected: N= 13, mean= 21, SE= 3.757), will not last that long (Overall: N= 24,
mean= 16.08, SE= 2.65; Previously infected: N= 16, mean= 16.5625, SE= 3.387;
Uninfected: N= 8, mean= 15.125, SE= 4.79), will have no effect (Overall: N= 15,
mean= 12.73, SE= 2.68; Previously infected: N= 9, mean= 11.555, SE= 4.516;
Uninfected: N= 6, mean= 14.5, SE= 5.531), will improve their mental wellbeing
(Overall: N= 5, mean= 19, SE= 6.89; Previously infected: N= 3, mean= 13.33,
SE= 7.822; Uninfected: N= 2, mean= 27.5, SE= 9.579), or did not experience
social isolation (Overall: N= 10, mean= 19.9, SE= 4.42; Previously infected: N=
2, mean= 11.5, SE= 9.579; Uninfected: N= 8, mean= 22, SE= 4.79).
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Figure 3.11 (continued): Effect on Mental Wellbeing. B) Mean Beck’s Depression
Inventory Score for participants who believe that the social isolation they
experienced will have effects on their mental wellbeing that will last for a long
time (Overall: N= 30, mean= 18.1667, SE= 1.53; Previously infected: N= 17,
mean= 22.0588, SE= 1.754; Uninfected: N= 13, mean= 13.0769, SE= 2.006), will
not last that long (Overall: N= 24, mean= 10.875, SE= 1.53; Previously infected:
N= 16, mean= 10.25, SE= 1.808; Uninfected: N= 8, mean= 12.125, SE= 2.557),
will have no effect (Overall: N= 16, mean= 7.8125, SE= 1.82; Previously infected:
N= 10, mean= 8.6, SE= 2.287; Uninfected: N= 6, mean= 6.5, SE= 2.953), will
improve their mental wellbeing (Overall: N= 5, mean= 10.6, SE= 2.01; Previously
infected: N= 3, mean= 9.33, SE= 4.175; Uninfected: N= 2, mean= 12.5, SE=
5.114), or did not experience social isolation (Overall: N= 10, mean= 9.4, SE= 2;
Previously infected: N= 2, mean= 7, SE= 5.114; Uninfected: N= 8, mean= 10,
SE= 2.557).
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Figure 3.11 (continued): Effect on Mental Wellbeing. C) Mean Adult ADHD SelfTest scores for participants who believe that the social isolation they experienced
will have effects on their mental wellbeing that will last for a long time (Overall:
N= 30, mean= 63.5, SE= 4.99; Previously infected: N= 17, mean= 66.8235, SE=
6.353; Uninfected: N= 13, mean= 59.1538, SE= 7.265), will not last that long
(Overall: N= 24, mean= 44.66, SE= 5.08; Previously infected: N= 16, mean=
46.375, SE= 6.548; Uninfected: N= 8, mean= 41.25, SE= 9.261), will have no
effect (Overall: N= 16, mean= 36.06, SE= 6.9; Previously infected: N= 10, mean=
36.9, SE= 8.283; Uninfected: N= 6, mean= 34.66, SE= 10.693), will improve their
mental wellbeing (Overall: N= 5, mean= 40.2, SE= 6.58; Previously infected: N=
3, mean= 44, SE= 15.122; Uninfected: N= 2, mean= 34.5, SE= 18.521), or did
not experience social isolation (Overall: N= 10, mean= 44.9, SE= 6.78;
Previously infected: N= 2, mean= 36, SE= 18.521; Uninfected: N= 8, mean=
47.125, SE= 9.261).

75

Figure 3.12: Effect on Mental Abilities. A) Mean Beck’s Anxiety Inventory scores
for participants who believe that the social isolation they experienced will have
effects on their mental abilities that will last for a long time (Overall: N= 22,
mean= 19.4091, SE= 1.83; Previously infected: N= 14, mean= 22.571, SE=
1.995; Uninfected: N= 8, mean= 13.875, SE= 2.639), will not last that long
(Overall: N= 25, mean= 10.92, SE= 1.37; Previously infected: N= 17, mean=
10.353, SE= 1.81; Uninfected: N= 8, mean= 12.125, SE= 2.639), will have no
effect (Overall: N= 27, mean= 10.4074, SE= 1.52; Previously infected: N= 15,
mean= 10.733, SE= 1.927; Uninfected: N= 12, mean= 10, SE= 2.155), will
improve their mental wellbeing (Overall: N= 1, mean= 3, SE= 0; Previously
infected: N= 0, mean= , SE= ; Uninfected: N= 1, mean= 3, SE= 0), or did not
experience social isolation (Overall: N= 10, mean= 9.4, SE= 1.98; Previously
infected: N= 2, mean= 7, SE= 5.278; Uninfected: N= 8, mean= 10, SE= 2.639).
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Figure 3.12 (continued): Effects on Mental Abilities. B) Mean Dyslexia Checklist
scores for participants who believe that the social isolation they experienced will
have effects on their mental abilities that will last for a long time (Overall: N= 22,
mean= 6.4091, SE= 0.95; Previously infected: N= 14, mean= 6, SE= 1.014;
Uninfected: N= 8, mean= 7.125, SE= 1.341), will not last that long (Overall: N=
25, mean= 4.12, SE= 0.757; Previously infected: N= 17, mean= 3.765, SE= 0.92;
Uninfected: N= 8, mean= 4.875, SE= 1.341), will have no effect (Overall: N= 27,
mean= 3.5926, SE= 0.6; Previously infected: N= 15, mean= 3.4, SE= 0.98;
Uninfected: N= 12, mean= 3.833, SE= 1.095), will improve their mental wellbeing
(Overall: N= 1, mean= 1, SE= 0; Previously infected: N= 0, mean= , SE= ;
Uninfected: N= 1, mean= 0, SE= 0), or did not experience social isolation
(Overall: N= 10, mean= 7, SE= 1.06; Previously infected: N= 2, mean= 9, SE=
2.683; Uninfected: N= 8, mean= 6.5, SE= 1.341).
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Figure 3.12 (continued): Effects on Mental Abilities. C) Mean Adult ADHD SelfTest scores for participants who believe that the social isolation they experienced
will have effects on their mental abilities that will last for a long time (Overall: N=
22, mean= 67.0455, SE= 4.93; Previously infected: N= 14, mean= 73.357, SE=
6.919; Uninfected: N= 8, mean= 56, SE= 9.153), will not last that long (Overall:
N= 25, mean= 42.36, SE= 5.06; Previously infected: N= 17, mean= 39.882, SE=
6.279; Uninfected: N= 8, mean= 47.625, SE= 9.153), will have no effect (Overall:
N= 27, mean= 43.89, SE= 5.63; Previously infected: N= 15, mean= 44.933, SE=
6.685; Uninfected: N= 12, mean= 42.583, SE= 7.474), will improve their mental
wellbeing (Overall: N= 1, mean= 36, SE= 0; Previously infected: N= 0, mean= ,
SE= ; Uninfected: N= 1, mean= 36, SE= 0), or did not experience social isolation
(Overall: N= 10, mean= 44.9, SE= 6.78; Previously infected: N= 2, mean= 36,
SE= 18.307; Uninfected: N= 8, mean= 47.125, SE= 9.153).
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Figure 3.13: Expectancies for Social Isolation. A) Frequencies for individuals who
thought that social isolation from the COVID-19 pandemic would have effects on
their mental wellbeing that would last for a long time (Previously infected= 17,
Uninfected= 13), would not last for a long time (Previously infected= 17,
Uninfected= 8), would have no effect on their mental wellbeing (Previously
infected= 10, Uninfected= 6), had improved their wellbeing (Previously infected=
3, Uninfected= 4), did not experience social isolation (Previously infected= 2,
Uninfected= 8), and declined to answer (Previously infected= 1, Uninfected= 1).
B) Frequencies for individuals who thought that social isolation from the COVID19 pandemic would have effects on their mental abilities that would last for a long
time (Previously infected= 14, Uninfected= 8), would not last for a long time
(Previously infected= 17, Uninfected= 8), would have no effect on their mental
abilities (Previously infected= 16, Uninfected= 12), had improved their mental
abilities (Previously infected= 0, Uninfected= 1), did not experience social
isolation (Previously infected= 2, Uninfected= 8), and declined to answer
(Previously infected= 2, Uninfected= 1).
79

Figure 3.14: Quarantine Activities. The Mean number of activities that previously
infected and COVID-19 uninfected groups participated in from March 15th-August
15th 2020 (Previously infected: M= 1.46, SE= 0.09, uninfected: M= 1.55, SE=
0.17), August 15th – January 15th, 2021 (Previously infected: M= 2.62, SE= 0.19,
uninfected: M= 2.53, SE= 0.23), January 15th – May 15th 2021 (Previously
infected: M= 3.16, SE= 0.22, uninfected: M=2.92, SE= 0.25), and May 15th 2021
to present (Previously infected: M= 3.82, SE= 0.21, uninfected: M= 3.55, SE=
0.26).
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Figure 3.15: Sense of Taste and Smell in COVID-19 Recovered groups. Did not
lose (taste= 22, smell= 26), lost, but has fully recovered (taste= 23, smell= 22),
lost but has not returned to normal (taste= 4, smell= 2).
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CHAPTER 4
DISCUSSION
4.1 OVERVIEW
Initial research has supported the possibility that COVID-19 may damage
the CNS either directly or indirectly. The present study sought to determine the
extent of these potential cognitive deficits in a young and mildly infected sample
of college students who lived through the COVID-19 pandemic. Participants
completed an extensive survey assessing their experience with COVID-19 and
any pandemic-induced social isolation and also completed a battery of cognitive
assessments to evaluate attention, memory, and executive functioning. Results
largely suggested that mild infection did not cause lasting cognitive deficits.
Social isolation largely did not influence cognition, but it had an effect on nondiagnostic measures of certain mental health disorders. The potential reasons for
these findings will be discussed below.
4.2 ATTENTION
There were no significant findings for the vigilance task, suggesting that
COVID-19 infection had no effect on sustained attention. In vigilance
assessments of COVID-19 survivors thus far, deficits were only observed in
recently hospitalized patients or severely infected patients; observed deficits had
ameliorated after 9 months (do Carmo Filho et al., 2022; Hampshire et al., 2021;
Zhao et al., 2022). It should be noted that the vigilance task in the present study
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took approximately 12 minutes to complete. While it was the longest of the
assessments, some assessments of vigilance and sustained attention can last
for 30 minutes or longer. Remaining vigilant for a longer period of time is more
difficult than for a shorter period of time, so it is possible that the length of the
vigilance task used was not long enough to prove challenging for the participants.
There were no significant findings for the Flanker task, indicating that
selective attention abilities were not significantly different between any of the
groups. Previous research indicates deficits in attention, but these deficits have
only been observed in hospitalized patients, severely infected patients, or in
patients diagnosed specifically with “long-COVID” (Jaywant et al., 2021; Almeria
et al., 2020; Hampshire et al., 2021; Graham et al., 2021).
Thus, using evidence from these assessments of attention, attentional
processes seem to be spared in previously mildly COVID-19 infected individuals
who have not been diagnosed with PCC. These findings suggest that extensive
damage to the neural correlates for these processes (middle frontal gyrus,
parietal lobe, prefrontal cortex, amygdala, HPA axis, orbitofrontal cortex, anterior
cingulate cortex) is unlikely due to the lack of expected deficits observed (Lewin
et al., 1996; Oken et al., 2006; Salo et al., 2017; Luks et al., 2010; Rusnáková et
al., 2011; vel Grajewska et al., 2011).
4.3 MEMORY
There were no significant effects of COVID-19 infection, nor any
interactions with biological sex, observed for the Digit Span task. Digit span tasks
are meant to assess verbal working memory. In a small study of young,
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previously COVID-19 infected individuals (N=10) compared to COVID-19
uninfected (N=19) individuals, verbal working memory deficits were observed
using a letter span task (Yoo, 2022). However, for Yoo’s study, it is unclear how
long the COVID-19 group had to recover before assessment. It is likely that the
present sample reflects that of previous studies wherein individuals did not
display long-term working memory deficits after sufficient recovery time (Guo et
al., 2022; Hampshire et al., 2021; Mattioli et al., 2021; Zhao et al., 2022).
Similarly, there were no significant effects of COVID-19 infection, nor any
interactions with biological sex, observed for the Emotional Memory task aside
from distractor word accuracy, wherein COVID-19 uninfected males
outperformed all other groups. A recent study conducted during the first year of
the COVID-19 pandemic showed that aversive emotional memories were
recalled and recognized at a lower rate than expected (Leon et al., 2022). While
the present sample did not have any differences between COVID-19 uninfected
and previously infected COVID-19 groups, there were the expected memory
differences between non-emotional and emotional words. It does not seem that
COVID-19 infection nor social isolation had any extra effect on emotional
memory. However, these null findings should not negate the findings of others
who have found that older individuals were better at emotional regulation and
were more likely to report positive memories from the pandemic than younger
individuals (Carstensen et al., 2020; Ford et al., 2021). The potential long-term
effects of the pandemic on younger individuals remain to be seen, but it is
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possible that long-term memory (which was not assessed herein) could be
affected in younger individuals more than the delayed memory task chosen.
There were no significant findings for the match to sample task, indicating
that visuospatial working memory ability was not significantly different between
any groups. It has previously been found that deficits in memory have been
observed in recovered COVID-19 patients, and those with neurological
symptoms had even lower scores in working memory than those without
neurological symptoms (Alemanno et al., 2021; Becker et al., 2021; Graham et
al., 2021; Mendez et al., 2021; Hampshire et al., 2021; Jaywant et al., 2021;
Almeria et al., 2020). However, other studies in COVID-19 positive populations
indicated the lack of long-term working memory and emotional processing
deficits (Guo et al., 2022; Hampshire et al., 2021; Mattioli et al., 2021; Zhao et al.,
2022). It seems that the present sample better matches the latter, especially
considering that the present sample was not seriously physically affected by
COVID-19 infection, nor was anyone in the sample hospitalized. Similarly, there
were no significant findings for the change detection task, indicating that there
were no significant differences between any groups on working memory capacity.
Interestingly, it has been previously found that increased working memory
capacity was a predictor of social-distancing compliance during the height of the
COVID-19 pandemic in the United States (Xie et al., 2020). The aforementioned
study was conducted during the first 2 weeks of the government mandated
lockdowns in the United States. This finding was not replicated in the present
sample; the present assessment of working memory capacity did not correlate
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significantly to the assessment of quarantining for the months of March to August
of 2020.
Thus, using evidence from these assessments of memory, these facets of
memory seem to be spared in previously mildly COVID-19 infected individuals.
These findings suggest that extensive damage to the neural correlates for these
processes (dorsolateral prefrontal cortex, parietal cortex, anterior cingulate
cortex, basal ganglia, fusiform gyrus, inferior frontal gyrus, orbitofrontal cortex,
and hippocampus) is unlikely due to the lack of expected deficits observed
(Aleman et al., 2008; Geva et al., 2021; Hoshi et al., 2000; Daniel et al., 2016;
Habeck et al., 2004; Cirillo et al., 1989; Beck et a., 2001; Kuchinke et al., 2005;
Bowen et al., 2018).
4.4 EXECUTIVE FUNCTIONING
There were no significant findings for Berg’s Card Sorting task aside from
a significant interaction between previous COVID-19 infection status and
biological sex, with never infected males significantly outperforming all other
categories. Card Sorting Task performance is thought to be mediated by the
ventrolateral and dorsolateral prefrontal cortex, anterior cingulate cortex, and
inferior parietal lobe (Buchsbaum et al., 2005; Nagahama et al., 1996; Lie et al.,
2006). Overall, there were no differences between previously COVID-19 infected
and COVID-19 uninfected groups on Mean number of card sorts before correctly
sorting. The Card Sorting task is meant to assess cognitive flexibility, which can
be considered a facet of executive functioning. It is likely that the present sample
reflects that of other studies that have assessed executive functioning and found
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amelioration of initial deficits in a sample that has had sufficient time to recover
from COVID-19 infection (Guo et al., 2022; Mattioli et al., 2021; Zhao et al.,
2022).
There were no significant findings for the Iowa Gambling task aside from
the significant correlation between social isolation scores and the “proportion of
disadvantageous draws in the last half of the task” measure. The Iowa Gambling
Task used herein consisted of 100 draws from 4 decks. To ensure that risktaking behavior and decision making was being assessed, and not random
chance, the last 50 draws were the focus of the present assessments. It should
be noted that all participants sampled from all decks at least once during the first
25 trials of the task.
Previously COVID-19 infected and COVID-19 uninfected groups were no
different in the proportion of high-risk-high-reward choices nor frequent-risk-highreward choices they made in the last half of the task. Since all participants had,
and took advantage of, the opportunity to sample from all decks by the last half of
the task, this lack of difference between groups indicates that one group was not
more likely to engage in risk-taking behavior than the other.
Previously COVID-19 infected and COVID-19 uninfected groups were also
no different in the proportion of disadvantageous draws they made in the last half
of the task. Previous literature suggests that Iowa Gambling Task selections
improved consistently as “lockdown” restrictions were reduced; in other words,
selection from beneficial decks increased and selection from disadvantageous
decks decreased (Ingram et al., 2021). Previously COVID-19 infected and
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COVID-19 uninfected groups were not different in their ability to avoid
disadvantageous decks in the last half of the task (“disadvantageous early versus
late”). It should be noted that, regardless of biological sex or COVID-19 infection
status, on average all participants improved in their ability to avoid
disadvantageous decks (M=1.26, SE=0.152). In other words, COVID-19 infection
had no effect on one’s ability to improve in the Iowa Gambling Task over time,
indicating that learning the task, learning from past mistakes, and improving
decisions over time was not impaired.
Thus, using evidence from these assessments of executive functioning,
these abilities seem to be spared in previously mildly COVID-19 infected
individuals. These findings suggest that extensive damage to the neural
correlates for these processes (ventrolateral and dorsolateral prefrontal cortex,
anterior cingulate cortex, insula, basal ganglia, frontal gyrus, lateral orbitofrontal
cortex, and inferior parietal lobe) is unlikely due to the lack of expected deficits
observed (Buchsbaum et al., 2005; Nagahama et al., 1996; Lie et al., 2006; Lin
et al., 2008; Lawrence et al., 2009).
4.5 SOCIAL ISOLATION
Social isolation scores positively correlated significantly with number of
symptoms endorsed for depression, dyslexia, ADHD, and autism spectrum
disorder. It is unknown whether social isolation exacerbated the symptoms
associated with these disorders or whether having a higher number of symptoms
in these disorders cause individuals to be more socially isolated. Previous
literature indicates that social isolation is significantly correlated with depression
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(Matthews et al., 2016; Courtet et al., 2020), dyslexia (Mugnaini et al., 2009;
Baschenis et al., 2021), ADHD (Brod et al., 2012; Sibley et al., 2021), and autism
(Kasari and Sterline, 2013). It was initially expected that social isolation would
have more prevalence as an influencing factor in the results. However, it is also a
possibility that the effects of social isolation due to the pandemic are no longer
observable. Data collection for the present study began in the Fall of 2021. By
this time, most university services, sporting events, dormitories, and classrooms
were back to their pre-pandemic operating procedures; in addition, surrounding
restaurants and other social activities were fully open, and many had been since
earlier in the year when vaccinations were becoming widely available. There can
be no doubting the potential trauma and negative effects that prolonged social
isolation had on some individuals, especially those who voluntarily quarantined
longer and more strictly than the majority of the population. However, if there was
a more widespread effect of social isolation, the current measures used for the
present study were not sensitive or relevant enough to pick up on any of those
potential differences.
There was a significant correlation observed between backward digit-span
ability and social isolation. However, upon accounting for dyslexia (which also
correlated with backward digit-span ability), the contribution of social isolation
scores to the regression model was determined to be minimal. Assessing
backward digit-span ability during the COVID-19 pandemic has shown no
significant effect of isolation on task performance (Manca et al., 2022). Because
of the low contribution of social isolation scores to an overall regression model
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once dyslexia measures were added to the model, it is likely that social isolation
does not have a clinically significant effect on backward digit-span task
performance. There is evidence to support that social isolation could affect
memory in later life (Evans et al., 2018), but other assessments of social isolation
have shown no significant effect on this ability (Zubek et al., 1969).
While there were no group differences associated with COVID-19 infection
for the Iowa Gambling Task, there was a significant relationship found between
social isolation scores and proportion of disadvantageous draws during the last
50 trials. As social isolation scores increased (thus indicating greater levels of
isolation), disadvantageous draws in the last half of the task significantly
decreased. This is the opposite of the relationship found by Ingram et al. (2021).
Upon graphical inspection, it is clear this trend is being influenced by the
previously COVID-19 infected group only, as the COVID-19 uninfected group has
a slope near zero. In fact, a regression model excluding the COVID-19
uninfected group is still significant (p=0.015) and has a stronger R square value
(0.176 as compared to 0.074); a model including only the COVID-19 uninfected
group is not significant (p=0.963) (Figure 3.6D). This indicates that in the COVID19 infected group alone is responsible for the overall trend, such that: %
disadvantageous draws in the last half= 0.809 + (-0.007 * social isolation score).
This finding is especially unique upon considering that the COVID-19 uninfected
and previously COVID-19 infection groups did not differ in mean levels of social
isolation. The present data indicates that the higher one’s social isolation score
was, the lower proportion of disadvantageous draws in the last half of the Iowa
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Gambling Task that individual made; this trend was only observed in the
previously COVID-19 infected group. For this group only, higher social isolation
scores were beneficial for task performance.
This finding prompted an additional look at the dataset to determine whether
there were other social isolation differences between groups on any of the
cognitive measures. The only other discrepancy observed between these groups
in relation to social isolation was on the total number of misses for the Vigilance
task. There was a significant relationship found between number of misses and
social isolation scores, but only in the COVID-19 uninfected group (F(1,
30)=6.796, R2=0.185, p=0.014) and not in the previously COVID-19 infected
group (F(1, 43)=0.285, p=0.596) (Figure 4.16). In other words, for the COVID-19
uninfected group, but not the previously COVID-19 infected group, as social
isolation scores increased, so did number of misses, such that: number of
misses= -9.269 + (0.275 * social isolation score). It is unclear why these two
patterns were observed, but it importantly provides further evidence that there
are potential group differences between COVID-19 uninfected and previously
COVID-19 infected individuals. More specifically, social isolation may have
affected these populations differently, potentially becoming either a harmful or a
beneficial mechanism that differs depending on infection status and the task at
hand.
4.6 SEX DIFFERENCES
For Berg’s Card Sorting Task, there was a significant interaction between
previous COVID-19 infection status and biological sex, with never infected males
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significantly outperforming all other categories. Based on previous literature for
the Wisconsin Card Sorting Task, sex differences in this direction were not
anticipated. Women have either outperformed men or both men and women
have been found to perform equally on CST performance (Boone et al., 1993;
van den Bos et al., 2013). However, based on the current data, it is suggested
that COVID-19 infection induced deficits in CST performance in males and not
females; this finding had a medium effect size. Card Sorting Task performance is
thought to be mediated by the ventrolateral and dorsolateral prefrontal cortex,
anterior cingulate cortex, and inferior parietal lobe (Buchsbaum et al., 2005;
Nagahama et al., 1996; Lie et al., 2006). It is possible that COVID-19 infection
and subsequent neuroinflammation causes damage to one of these areas more
severely in males than in females. However, other tasks examined that were
mediated by these same brain regions did not display the same sex effect as the
Card Sorting Task, so it is possible that these sex differences observed are
extremely task-specific.
There was also an interaction between COVID-19 infection status and
biological sex observed for the Emotional Memory task for distractor word
accuracy, wherein COVID-19 uninfected males outperformed all other groups;
this finding can be described as having a medium effect size. For the emotional
memory task, negative, positive, and neutral words that were both targets and
distractor words were presented during the recognition phase. The COVID-19
uninfected biological male group had significantly higher accuracy for
determining whether a distractor word was or was not present in the initial list,
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regardless of the valence of the word. It is unclear why this finding was
significant; this represents the second finding where the COVID-19 uninfected
biological male group outperformed all others. It is possible that this group was
unintentionally comprised of high performers in a proportion that was not present
in the other groups. However, the variance observed in this group among all
tasks was consistent with the other 3 groups, and there were no significant
outliers identified, so it is unlikely that this group is being influenced by only a few
individuals. Of note, the COVID-19 uninfected biological male group was the
least vaccinated proportionally than the other groups (76.9% vaccinated
compared to 82.9% for female previous COVID-19 infected, 91.7% male
previous COVID-19 infected, and 92% female COVID-19 uninfected), however
there is no known cognitive advantages, disadvantages, or protective factors
associated with COVID-19 vaccination, so this observation is potentially moot. A
recent study conducted during the first year of the COVID-19 pandemic showed
that aversive emotional memories were recalled and recognized at a lower rate
than expected (Leon et al., 2022). While the present sample did not have any
differences between COVID-19 uninfected and previously infected COVID-19
groups, there were the expected memory differences between non-emotional
and emotional words. It does not seem that COVID-19 infection nor social
isolation had any extra effect on emotional memory. However, these null findings
should not negate the findings of others who have found that older individuals
were better at emotional regulation and were more likely to report positive
memories from the pandemic than younger individuals (Carstensen et al., 2020;
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Ford et al., 2021). The potential effect long term effects of the pandemic on
younger individuals remain to be seen, but it is possible that long-term memory
(which was not assessed herein) could be affected in younger individuals more
than the delayed memory task chosen.
4.7 OTHER FINDINGS AND LIMITATIONS
Cognitive tasks were chosen for inclusion based on their literature-based
relationships to the cognitive constructs of interest. In general, these tasks were
minimally modified versions of existing experiments that have been well studied
experimentally (e.g., Change Detection) or are commonly used as part of
common neuropsychological tests (e.g., Digit Span, Berg Card Sorting Task,
Iowa Gambling Task).
The included measures of working memory capacity have generally
shown to be reliable, both in terms of internal consistency and stability across
testing sessions. Digit span is typically used as part of the Weschler Adult
Intelligence Scale and has estimated internal consistency of 0.83 and a testretest reliability of 0.65, although this varies by age group (Waters et al., 2003).
Change detection has become a common task for assessing non-verbal working
memory capacity and recent studies have estimated internal consistency
(Cronbach’s alpha) of around 0.92 and split-half reliability of between 0.76 and
0.91 (Xu et al., 2018; Dai et al., 2019). Continuous performance tasks to assess
vigilance or sustained attention generally have moderate to high internal
consistency (0.85) and test-retest reliability (ICC ~0.5) (Raz et al., 2014). Flanker
tasks also typically have high internal consistency (0.84 to 0.94) and test-retest
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reliability (ICC= .73-.82) (e.g., Paap et al., 2016). However, the Flanker task used
herein, as previously mentioned, used slightly different stimuli.
Despite their widespread use, however, many of these tasks have only
modest internal consistency or test-retest reliability. The Match to Sample task is
used as part of multiple neuropsychological batteries and has modest test-retest
reliability (0.56; Lowe et al., 1998) and an Emotional Memory task similar to the
one used herein has a similar test-retest reliability of around .5 (Thomas et al.,
2016). The Berg Card Sorting Task/Wisconsin Card Sorting Task is a widely
used neuropsychological assessment that has reasonable internal consistency
(Kopp, Lange, & Steinke, 2021) and test-retest reliability (Tate, Perdices, &
Maggiotto, 1998), although it has also been shown to produce practice effects
with repeated administration (Basso et al., 2001). Similarly, the sequential
learning that takes place during the Iowa Gambling Task appears to result in low
to moderate internal consistency and test-retest reliability (Buelow & Barnhart,
2018; Schmitz et al., 2020).
Despite the lower reliability of some of the cognitive tasks, these tasks
were included due to their widespread use, both clinically and experimentally,
and the relationship between their underlying cognitive constructs and other viral
infections. However, it is possible that these specific tasks were not ideal for
detecting the COVID-19 related cognitive changes of interest. In addition, due to
the time constraints of the experiment, many of the tasks used were modified to
be shorter in duration than the versions that are commonly used in the literature,
which may have reduced the ability to detect differences in the task.
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There was a significant, negative correlation between “days since COVID19 infection” and number of dyslexia and number of depression symptoms. This
finding indicates that the longer it has been since being infected with COVID-19,
the lower the number of symptoms for dyslexia and depression one reports. This
correlation provides further evidence of recovery over time, which has been
observed in prior literature (Guo et al., 2022; Williams et al., 2021; Zhao et al.,
2022; Mazza et al., 2021; Ferrucci et al., 2021; Kujawa et al., 2020). It is possible
that our sample reflected a population that was not only completely resolved of
the symptoms of active COVID-19 infection, but also potentially resolved of any
PCC as well. The mean “days since COVID-19 infection” for the present sample
was around 300 days, which far surpasses the timeframe seen in the majority of
current PCC literature. In acute respiratory distress syndrome, cognitive
impairment has been found to still have a 20% prevalence rate up to 5 years
after hospital discharge (Herridge et al., 2016). While findings related to acute
respiratory distress syndrome may be useful for populations that have been
seriously infected with COVID-19, it is unclear how long cognitive symptoms may
persist in a population that has not experienced extreme respiratory distress.
The consistent occurrence of the dyslexia assessment as an influential
variable in the present analyses cannot be ignored. Presence of dyslexia or
dyslexia related symptoms can affect one’s performance on certain cognitive
tasks, especially those that require reading comprehension to complete the task
or to understand the instructions. The regular appearance of number of dyslexia
symptoms in many of the cognitive variables as a covariate prompted a closer
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look at the symptoms that were most consistently selected by the present
sample. The items most frequently endorsed by the sample were (starting with
the most frequently endorsed):
•
•
•
•

Do you find it difficult to remember the sense of what you have read?
Do you take longer than you feel you should to read a page of a book?
Do you dislike reading long books?
Do you get confused if you speak in public?
While these items have been validated as part of the scale, these items

may not traditionally meet the expected definition of dyslexia. These symptoms
could simultaneously be measuring a different construct in addition to dyslexia,
perhaps attention. It is also worth noting that the present sample consistently
endorsed more symptoms of dyslexia than what was expected based upon the
parameters of the assessment. While the original assessment predicts 40% of
the sample to have more than 4 symptoms, 44% of the sample had more than 4
symptoms. The original assessment also predicts only 10% of the sample to
have more than 8 symptoms, while the sample had 18% showing more than 8
symptoms. In brief, the consistent relationship between dyslexia and many of the
present measures could be because the dyslexia assessment is also picking up
on other domains, such as attention or social anxiety. It could also be that the
individuals in the present sample may be displaying more symptoms of dyslexia
than were expected due to the effects of the pandemic.
The majority (83%) of the sample for the present study was vaccinated. It
should be noted that, of the previously COVID-19 infected individuals, 15 of
those that were vaccinated were vaccinated before contracting COVID-19, while
24 of the vaccinated were vaccinated after contracting COVID-19. It is presently
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unknown the effect that vaccination has on cognitive abilities, or the effect that it
may have on recovering from potential cognitive consequences of COVID-19.
Vaccination differences between the different brands available are also presently
unknown. For the present sample, vaccination status had no significant effect on
any cognitive or mental wellbeing measure, so the present data does not suggest
that vaccination is harmful or beneficial to the variables observed.
There exists an obvious disconnect between previously reported deficits
and the lack of observed deficits in the present study. Firstly, 47 individuals in the
present study identified that they thought the COVID-19 pandemic had a
significant effect on their cognitive abilities, with 22 of those individuals reporting
that they felt those effects would last “for a long time.” Subsequent analyses
showed that these groups did not perform any differently on any of the cognitive
measures than those that did not believe the pandemic would have a significant
effect on their cognitive abilities. As expected, the “effects will last for a long time”
group consistently displayed the greatest number of symptoms for depression,
dyslexia, or ADHD. It makes logical sense that the group that believes that
negative effects on mental wellbeing will continue to occur for a long period of
time will also have a greater of numbers of symptoms for depression and anxiety.
Since ADHD is frequently comorbid with anxiety and depression, it is not
surprising that this domain displayed a similar pattern (Schatz and Rostain,
2006). The “effect on mental abilities” analyses displayed a similar pattern, with
the “effects will last for a long time” group displaying significantly more symptoms
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of depression, dyslexia, and ADHD. These expectancies did not translate into
observable deficits.
Cognitive deficits are prevalent in prior literature, but evidence for these
deficits was not found in the current study. This could be for several reasons.
Much of the early literature for cognitive complaints following COVID-19 relied
heavily on self-report measures and anecdotal data from patients (Gordon et al.,
2021; Grover et al., 2021; Davis et al., 2021; Hampshire et al., 2021). Patient
self-advocacy is important and could even be uniquely responsible for helping to
legitimize “long-COVID” as an illness (Callard et al., 2021). However, it is
possible that patient reporting could be swayed by media misinformation or
excessive worry about their infection status, thus causing them to overestimate
or overanalyze their perceived deficits (Micallef et al., 2020). While resources
were limited during the early pandemic stages, follow-up with validated cognitive
assessments should be used in cases where patients complain of cognitive
deficits, especially patients who were hospitalized or may be experiencing certain
forms of “post-COVID syndrome.”
There is also the possibility that individuals who were previously infected
are overestimating their “cognitive deficits” because they are underestimating
themselves. The COVID-19 pandemic caused global shutdowns, which led to
many individuals working from home, attending classes virtually, changing
careers, or even losing their jobs. This environment change led to a shift, and
oftentimes an increase, in responsibilities. The change in expectations frequently
came in conjunction with decreases in supervision, immediate feedback, and
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cues from workplace peers. With many individuals losing their employment or
their “spots” in higher education, a sense of “survivor’s guilt” is also possible
among individuals who remain in employment or higher education (Hutchins et
al., 2017; Bravata et al., 2020). These factors combined create a perfect situation
for the development of “Imposter Syndrome,” a phenomenon that occurs when
an individual doubts their abilities and accomplishments, feels “like a fraud,” or
does not feel as though they “belong” or have “earned their place”. The lack of
expected benchmark assessments (i.e., assignments or coursework being
restructured due to an online format) or feeling as though the information
obtained from previous coursework was not retained can also contribute to
feeling “like a fraud” in a degree program. The inability to compare one’s work to
another student, or to receive feedback from peers, mentors, or bosses can lead
to increased uncertainty in one’s own abilities. Put simply, an individual may be
functioning appropriately, but without the cues from others to let them know their
standing, that individual may result to holding their abilities to an impossible
standard. Rates of Imposter Syndrome are thought to be on the rise due to the
COVID-19 pandemic (Pownall et al., 2021; Golding, 2021).
It is also possible that the perceived deficits that individuals are selfreporting are more of an academic nature rather than a reflection of their basic
cognitive skills. The inability to pay attention for long periods of time such as
during reading or studying was observed in the present sample via the dyslexia
assessment, and the most frequently endorsed symptom of adult ADHD was “At
home, work, or school, I find my mind wandering from tasks that are
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uninteresting or difficult.” Potentially, the “cognitive” deficits that participants felt
they had were deficits related to their academic performance (such as issues
reading, taking notes, paying attention for a lengthy lecture) rather than their
everyday, basic cognitive functioning (remembering a shopping list, paying
attention while driving). Young adults (like the present sample) were put in a
difficult position regarding their education during the COVID-19 pandemic. Many
individuals completed high school virtually and were forced to choose between
attending college virtually (or “hybrid”) or take time off from their studies until
higher education largely returned to a face-to-face format. Satisfaction with online
education has been mixed even among individuals who had a choice between
virtual or in-person education (Blackmon et al., 2012). Additionally, satisfaction
with the learning experience has been identified as a correlate with cognitive and
learning outcomes for online courses (Heckel et al., 2019). Some individuals
chose to take a “gap year” before attending, or returning to, college, and others
lost out on valuable learning time due to school closures in Spring of 2020
because of the COVID-19 pandemic. Long breaks from the classroom can lead
to learning loss of not just course materials, but also the loss of learning
strategies that could be used to acquire new information (van de Sande et al.,
2018; Turner et al., 2020).
In addition, it is possible that because being a college student is an
inherently cognitively demanding task, individuals who had PCC with noticeable
cognitive decline as a symptom may have chosen not to enroll or reenroll in
higher education, and thus were not part of the population we sampled from.

101

While not possible for the current study, a larger community sample of young
adults may have been better able to identify changes in basic cognition after
COVID-19 infection. Lastly, as discussed similarly with social isolation, it is
possible that at one point the individuals in our current sample experienced
cognitive symptoms that could have been associated with PCC, but at the time of
testing they had recovered from those symptoms. Data collection did not begin
until Fall of 2021, and by this point it is possible that participants had made a full
recovery from any deficits they may have previously had outside of our testing
window.
There were several factors that set the present sample apart from others
that have assessed cognitive functioning post COVID-19 infection. Firstly, no
participant reported hospitalization from COVID-19. Much of the research
conducted thus far on the potential cognitive consequences of COVID-19
infection exclusively included previously hospitalized patients of COVID-19. In
addition, no participant in the present study reported severe symptoms
associated with COVID-19 infection, reported being diagnosed with PCC or
Long-COVID, nor did any participant require oxygen treatment. The present
sample represents mildly infected individuals who were able to recover outside of
a hospital, which is relevant as severity of infection has been heavily implicated
in severity of deficits seen at a later time point. The present research provides
more data to support that mildly infected individuals do not tend to display severe
deficits, especially when they’ve been given time to recover. No participant
indicated suffering from PCC. This could be for several reasons. PCC is not
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consistently diagnosed, and PCC does not have a current, agreed upon
definition. Therefore, even if participants went to a clinician with symptoms that
could be consistent with PCC, those symptoms may be ignored or misdiagnosed.
It is worth noting that, in the present sample, fatigue (as assessed by question 17
from the Beck Depression Inventory) was endorsed at similar rates between
previously COVID-19 infected and COVID-19 uninfected, with 33% and 30%
endorsing option 1, 48% and 46% endorsing option 2, 17% and 18% for option 3,
and 0% and 4% for option 4. However, despite our sample not claiming a
diagnosis of Long-COVID or PCC, nor endorsing fatigue at an increased rate, the
possibility that our sample was comprised of individuals with PCC cannot be
ruled out. In the future, studies should include a questionnaire for participants to
complete that assesses them for PCC, as a division of a previously COVID-19
group based upon the presence of lingering symptoms post infection would
create more valuable results.
A second strength of the current project is that the present sample
consists of young adults, which taps into a segment of the population that has not
been as extensively tested regarding COVID-19 infection. The lack of extensive
significant findings in the present research may also reflect the plasticity of the
developing brain to overcome damage that may be causing PCC.
There are several important limitations to consider when it comes to the
present study. Firstly, the sample size was likely not sufficient to detect group
differences, particularly when stratified by sex. As mentioned above, due to
difficulty recruiting enough participants, it is possible that we were unable to
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detect effects in our data. Moreover, the sample itself could have been more
diverse regarding biological sex, race, and ethnicity. Statistical analyses stratified
by race and ethnicity could not be reliably conducted due to the low amount of
individuals in certain groups. The effect sizes that were found in the limited
significant findings were of a medium size with few statistically significant
findings; it is possible that with more subjects new statistically significant results
could have emerged. The present study did not target certain participants to
recruit (i.e., participants of a certain COVID-19 infection status or participants of a
certain biological sex). This was done to increase the sample size as much as
possible, but a more targeted approach to recruitment could have better
balanced the planned groups. The present study was also unable to obtain preand post-infection measures, nor were we able to obtain pre- and post-pandemic
measures.
Certain factors were not assessed in the present study, as they were
outside of the scope of the research. However, they are important factors
nonetheless, and they may contribute in an important way to potential changes
between groups. Socioeconomic status, employment status (or employment loss
due to the pandemic), education achievements or delays, and deaths of loved
ones are all relevant factors to consider if one hopes to truly encompass the
effects the pandemic, global shutdowns and lockdowns, and social isolation may
have had on an individual, their family, and their community. Future research
should include items to assess these important factors that can affect the
individual.
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The cognitive testing of the study itself lasted approximately one hour. The
tasks changed frequently and required a variety of inputs, which assisted in
keeping participants interested and engaged with the task. However, all
participants may not have been diligent and attentive to the tasks at hand. This is
seen most prominently in the Iowa Gambling task, where many individuals were
automatically removed from the task for not engaging with it properly.
Participants were permitted to take breaks or leave the testing room between
tasks if they so desired, but very few of the participants chose to take any breaks
and most instead preferred to continue with the experiment without breaks. Data
on fatigue of the participant, both before and after cognitive testing, was not
collected. Future research should carefully consider the downsides of long-form
testing, especially in a population that may be inordinately suffering from fatigue.
Other individual differences, such as the amount of sleep obtained recently,
caffeine consumption, or medication adherence (or non-adherence) are also
known to influence performance on cognitive tasks. Future research should
perhaps aim to exclude or otherwise statistically account for participants who do
not meet certain “alertness” criteria. The cognitive assessments used, while
spanning many difference facets and domains of cognition, did not cover all
areas; prospective memory, social cognition, and long-term memory are
examples of cognitive domains that are equally important to quality of life and
could be assessed in future research.
An additional limitation is the unpredictable nature of the COVID-19
pandemic. During the planning and execution phase of the present project,
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restrictions have changed drastically, and new information is learned about
COVID-19 daily. In the past year alone, many individuals have gone from a place
of instability and worry to one of assurance and normalcy. For some, families
have been restructured, jobs have been lost, and important lives have been
taken by COVID-19. These changes will have a long-lasting impact on the mental
wellbeing of many individuals. However, hope for many has come from the
relative “re-opening” of society, the return to face-to-face lectures and meetings,
or the ability to travel and visit with friends and family without restriction. In
general, the “return to normal” for many individuals may have alleviated any
potential deficits that could have manifested because of longer restrictions and
periods of social isolation.
Concerning COVID-19 itself, many new variants have been discovered
since its initial identification. There is currently no quick and easy method to test
which variant an individual has been infected with, so the variant that an
individual has been infected with is up for speculation unless additional lab
testing is performed. If an easier and quicker way to identify COVID-19 strain is
developed, then strain differences should be examined to determine whether the
strain someone was infected with may influence their long-term health outcome.
However, for the present study, COVID-19 strain differences were not known. It
is also unknown what the long-term effects of the COVID-19 virus may have on
the body and brain. There is potential for the COVID-19 virus to lay dormant and
later “reactive,” similar to Herpes Zoster, although no evidence has yet supported
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this possibility. Even so, at present the COVID-19 virus is still incredibly new, and
long-term effects cannot be known.
It is unknown whether American society will again see the same levels of
quarantine, social isolation, and fear that was observed during the initial years of
the COVID-19 pandemic. It is possible that the surfacing of a new strain of
COVID-19 could again force individuals into social isolation. While the present
study showed that the social isolation experienced by many during the COVID-19
pandemic did not have as extensive of an influence as was previously thought, it
is entirely unknown what effects could manifest with a similar “shut down” so
soon after the previous one. It is worth noting that many participants in the
present study indicated that they believed the pandemic will affect them both
mentally and cognitively “for a long time,” despite all of the data collection
occurring when their university and surrounding city of Columbia, SC, was
relatively “open.”
4.8 CONCLUSIONS
The prominence of the many null findings in the present research provides
hope for those that were, or may be in the future, mildly infected with COVID-19.
While many individuals self-report deficits in their cognitive abilities, these deficits
were largely not measurable in the present sample. Ongoing cognitive deficits
seem to be most prevalent in individuals who were hospitalized or older, which
were two populations that were not represented in the present sample. Unique
attention by researchers and health professionals should be allotted to
individuals who perceive cognitive deficits but show no evidence of them; these
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individuals may instead be suffering from poor mental health. As the COVID-19
pandemic has continued, the view of the COVID-19 virus has been constantly
adapting, and new discoveries (such as vaccination) have changed the
landscape of the disease. While cognitive deficits and other symptoms of PCC
are of particular concern in specific populations and during certain stages of
COVID-19 infection, the current findings provide limited evidence for such deficits
in mildly infected young adults that have had a sufficient time to recover from
viral infection.
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Figure 4.1. Scatterplot of social isolation scores and number of misses during the
Iowa Gambling Task.
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APPENDIX A
GOOGLE FORM
Consent:
[ ] I consent to participate in this experiment and comply with all COVID-19 health
procedures.
[ ] I do not wish to participate at this time and would like to cancel my
appointment.

COVID-19 Screening
Please read through each of the following questions from the UofSC daily
COVID-19 screening form:
In the past 14 days:
- have you been diagnosed with the Novel Coronavirus/COVID-19?
- have you had a temperature reading of 100.0°F or higher or felt feverish?
- have you lived with or been within 6 feet of someone for 10 consecutive
minutes who has been diagnosed with COVID-19?
- have you lived with or been within 6 feet of someone for 10 consecutive
minutes who is quarantined or isolated due to suspicion of COVID-19?
In the past 7 days have you experienced any of the following symptoms:
- Cough
- Headache
- Shortness of breath
- Chills / shaking
- Sore throat
- Muscle aches
- Loss of taste or smell
Did you answer "yes" to any of the above questions?
[ ] Yes
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[ ] No

COVID-19 Questions:
Have you been vaccinated for COVID-19?
[ ] Yes, fully (two shots or one depending on vaccination)
[ ] I am "partially" vaccinated (one shot of a two shot vaccination series)
[ ] No, not vaccinated
[ ] Would prefer not to say
If vaccinated, which vaccine have you been vaccinated with?
[ ] I have not been vaccinated/would prefer not to say
[ ] Moderna
[ ] Pfizer/BioNTech
[ ] Johnson & Johnson/Janssen

Approximately when did you receive your first vaccination dose? If you have not
been vaccinated, or would prefer not to say, select January 1, 2019 (01/01/2019)

Have you ever been officially diagnosed by a medical professional (via nasal
swab, saliva, or antibody test) with COVID-19?
[ ] Yes
[ ] No

Yes, diagnosed with COVID-19 Questions:
When did you have COVID-19?

Which of the following best describes your experience with COVID-19?
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[ ] Individuals who test positive for SARS-CoV-2 using a virologic test (i.e., a
nucleic acid amplification test or an antigen test) but who have no symptoms that
are consistent with COVID-19.
[ ] Individuals who have any of the various signs and symptoms of COVID-19
(e.g., fever, cough, sore throat, malaise, headache, muscle pain, nausea,
vomiting, diarrhea, loss of taste and smell) but who do not have shortness of
breath, dyspnea, or abnormal chest imaging.
[ ] Individuals who show evidence of lower respiratory disease during clinical
assessment or imaging and who have saturation of oxygen (SpO2) ≥94% on
room air at sea level.
[ ] Individuals who have SpO2 <94% on room air at sea level, a ratio of arterial
partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO2) <300 mm
Hg, respiratory frequency>30 breaths/min, or lung infiltrates >50%.
[ ] Individuals who have respiratory failure, septic shock, and/or multiple organ
Dysfunction

Did you lose your sense of taste and smell?
Taste: [ ] Did not lose
[ ] Lost, but has now returned
fully returned back to "normal"

[ ] Lost, but has not

Smell: [ ] Did not lose
[ ] Lost, but has now returned
fully returned back to "normal"

[ ] Lost, but has not

If you have ever been diagnosed a second time with COVID-19. please provide
additional details below (such as when you were diagnosed a second time, if that
time was more severe than the first time, or if you lost taste/smell again)

Not diagnosed with COVID-19 Questions:
At any point, did you think that you had COVID-19 but were not officially
diagnosed?
[ ] Yes {reroutes back to “Yes, diagnosed with COVID-19 Questions”}
[ ] No
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Quarantine Questions:
Think back to the height of COVID-19 quarantining ("lockdown"). Please select
the activities that you regularly did IN PERSON during the specified period of
time. [March 15, 2020-August 15, 2020; August 15, 2020-January 15, 2021;
January 15, 2021-May 15, 2021; May 15, 2021-present]
See some family (excluding elderly relatives such as grandparents)
See all family (including elderly relatives such as grandparents)
See existing friends
Meet new people (such as at a bar, restaurant, or through a friend-of-a-friend)
Attend social gatherings (such as concerts, parties, weddings) consisting of 30+
people

If you experienced social isolation during COVID-19, do you personally think that
it has had lasting effects on your mental wellbeing (i.e., has it heightened any
depression, anxiety, etc.)?
[ ] Yes, and I think these effects will last for a long time
[ ] Yes, but I think these effects will not last for very long
[ ] No, my mental wellbeing has remained the same
[ ] No, and my mental wellbeing is better than it was before quarantine
[ ] I did not experience social isolation during COVID-19

If you experienced social isolation during COVID-19, do you personally think that
it has had lasting effects on your mental abilities (attention span, memory,
cognition)?
[ ] Yes, and I think these effects will last for a long time
[ ] Yes, but I think these effects will not last for very long
[ ] No, my mental wellbeing has remained the same
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[ ] No, and my mental wellbeing is better than it was before quarantine
[ ] I did not experience social isolation during COVID-19

For the following items, please indicate how often each of the statements below
is descriptive of you [Never, Rarely, Sometimes, Often].
1. How often do you feel that you are "in tune" with the people around you?
2. How often do you feel that you lack companionship?
3. How often do you feel that there is no one you can turn to?
4. How often do you feel alone?
5. How often do you feel part of a group of friends?
6. How often do you feel that you have a lot in common with the people around
you?
7. How often do you feel that you are no longer close to anyone?
8. How often do you feel that your interests and ideas are not shared by those
around you?
9. How often do you feel outgoing and friendly?
10. How often do you feel close to people?
11. How often do you feel left out?
12. How often do you feel that your relationships with others are not meaningful?
13. How often do you feel that no one really knows you well?
14. How often do you feel isolated from others?
15. How often do you feel you can find companionship when you want it?
16. How often do you feel that there are people who really understand you?
17. How often do you feel shy?
18. How often do you feel that people are around you but not with you?
19. How often do you feel that there are people you can talk to?
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20. How often do you feel that there are people you can turn to?

Do you think that you answers to the previous statements would have been
different if there had been no COVID-19?
[ ] Almost 100% of answers would have been different; I do not feel that the
answers I gave reflect how I "usually" feel
[ ] About 75% of answers would have been different
[ ] About 50% of answers would have been different
[ ] About 25% of answers would have been different
[ ] Almost 0% of answers would have been different; I feel that the answers I
gave reflect how I "usually" feel, pandemic or not

Questionnaires:
You are about to start a series of questionnaires that will allow us to examine
individual differences in cognition. All responses are voluntary and you can
decline to answer any question that you are not comfortable with. Your identity
will never be associated with your responses, only your assigned subject
number.
At the end of each questionnaire you will be prompted to press a button to
continue on to the next page. Once all questionnaires are completed you will be
prompted to press a button to submit your responses.

Beck Anxiety Inventory: Below is a list of common symptoms of anxiety. Please
carefully read each item in the list. Indicate how much you have been bothered
by that symptom during the past month, including today, by selecting the
corresponding button in the column next to each symptom. [Not at all; Mildly, but
it didn't bother me much; Moderately - it wasn't pleasant at times; Severely bothered me a lot]
1. Numbness or tingling
2. Feeling hot
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3. Wobbliness in legs
4. Unable to relax
5. Fear of worst happening
6. Dizzy or lightheaded
7. Heart pounding/racing
8. Unsteady
9. Terrified or afraid
10. Nervous
11. Feeling of choking
12. Hands trembling
13. Shaky / unsteady
14. Fear of losing control
15. Difficulty in breathing
16. Fear of Dying
17. Scared
18. Indigestion
19. Faint / lightheaded
20. Face flushed
21. Hot/cold sweats

Beck Depression Inventory
1.
0 I do not feel sad.
1 I feel sad
2 I am sad all the time and I can't snap out of it.
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3 I am so sad and unhappy that I can't stand it.
2.
0 I am not particularly discouraged about the future.
1 I feel discouraged about the future.
2 I feel I have nothing to look forward to.
3 I feel the future is hopeless and that things cannot improve.
3.
0 I do not feel like a failure.
1 I feel I have failed more than the average person.
2 As I look back on my life, all I can see is a lot of failures.
3 I feel I am a complete failure as a person.
4.
0 I get as much satisfaction out of things as I used to.
1 I don't enjoy things the way I used to.
2 I don't get real satisfaction out of anything anymore.
3 I am dissatisfied or bored with everything.
5.
0 I don't feel particularly guilty
1 I feel guilty a good part of the time.
2 I feel quite guilty most of the time.
3 I feel guilty all of the time.
6.
0 I don't feel I am being punished.
1 I feel I may be punished.
2 I expect to be punished.
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3 I feel I am being punished.
7.
0 I don't feel disappointed in myself.
1 I am disappointed in myself.
2 I am disgusted with myself.
3 I hate myself.
8.
0 I don't feel I am any worse than anybody else.
1 I am critical of myself for my weaknesses or mistakes.
2 I blame myself all the time for my faults.
3 I blame myself for everything bad that happens.
9.
0 I don't have any thoughts of killing myself.
1 I have thoughts of killing myself, but I would not carry them out.
2 I would like to kill myself.
3 I would kill myself if I had the chance.
10.
0 I don't cry any more than usual.
1 I cry more now than I used to.
2 I cry all the time now.
3 I used to be able to cry, but now I can't cry even though I want to.
11.
0 I am no more irritated by things than I ever was.
1 I am slightly more irritated now than usual.
2 I am quite annoyed or irritated a good deal of the time.
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3 I feel irritated all the time.
12.
0 I have not lost interest in other people.
1 I am less interested in other people than I used to be.
2 I have lost most of my interest in other people.
3 I have lost all of my interest in other people.
13.
0 I make decisions about as well as I ever could.
1 I put off making decisions more than I used to.
2 I have greater difficulty in making decisions more than I used to.
3 I can't make decisions at all anymore.
14.
0 I don't feel that I look any worse than I used to.
1 I am worried that I am looking old or unattractive.
2 I feel there are permanent changes in my appearance that make me look
unattractive
3 I believe that I look ugly.
15.
0 I can work about as well as before.
1 It takes an extra effort to get started at doing something.
2 I have to push myself very hard to do anything.
3 I can't do any work at all.
16.
0 I can sleep as well as usual.
1 I don't sleep as well as I used to.
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2 I wake up 1-2 hours earlier than usual and find it hard to get back to sleep.
3 I wake up several hours earlier than I used to and cannot get back to sleep.
17.
0 I don't get more tired than usual.
1 I get tired more easily than I used to.
2 I get tired from doing almost anything.
3 I am too tired to do anything.
18.
0 My appetite is no worse than usual.
1 My appetite is not as good as it used to be.
2 My appetite is much worse now.
3 I have no appetite at all anymore.
19.
0 I haven't lost much weight, if any, lately.
1 I have lost more than five pounds.
2 I have lost more than ten pounds.
3 I have lost more than fifteen pounds.
20.
0 I am no more worried about my health than usual.
1 I am worried about physical problems like aches, pains, upset stomach, or
constipation.
2 I am very worried about physical problems and it's hard to think of much else.
3 I am so worried about my physical problems that I cannot think of anything
else.
21.
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0 I have not noticed any recent change in my interest in sex.
1 I am less interested in sex than I used to be.
2 I have almost no interest in sex.
3 I have lost interest in sex completely.

Revised Dyslexia Checklist
1. Do you find it difficult telling left from right? Yes / No
2. Do you find map reading or finding your way to a strange place confusing?
Yes / No
3. Do you dislike reading aloud? Yes / No
4. Do you take longer than you feel you should to read a page of a book? Yes /
No
5. Do you find it difficult to remember the sense of what you have read? Yes / No
6. Do you dislike reading long books? Yes / No
7. Is your spelling poor? Yes / No
8. Is your writing difficult to read? Yes / No
9. Do you get confused if you speak in public? Yes / No
10. Do you find it difficult to take messages on the telephone and pass them on
correctly? Yes / No
11. When you have to say a long word, do you sometimes find it difficult to get all
the sounds in the right order? Yes / No
12. Do you find it difficult to do sums in your head without using your fingers or
paper? Yes / No
13. When using the telephone, do you tend to get the numbers mixed up when
you dial? Yes / No
14. Do you find it difficult to say the months of the year forwards in a fluent
manner? Yes / No
15. Do you find it difficult to say the months of year backwards? Yes / No
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16. Do you mix up dates and times and miss appointments? Yes / No
17. When writing cheques, do you frequently find yourself making mistakes? Yes
/ No
18. Do you find forms difficult and confusing? Yes / No

19. Do you mix up bus numbers like 19 and 91? Yes / No
20. Did you find it hard to learn your multiplication tables at school? Yes / No

Adult ADHD Self-Test: Please read each statement and indicate how much it
applies to you [Not at all; Just a little; Somewhat; Moderately; Quite a lot; Very
much]
1. At home, work, or school, I find my mind wandering from tasks that are
uninteresting or difficult.
2. I find it difficult to read written material unless it is very interesting or very
easy.
3. Especially in groups, I find it hard to stay focused on what is being said in
conversations.
4. I have a quick temper, a short fuse.
5. I am irritable and get upset by minor annoyances.
6. I say things without thinking, and later regret having said them.
7. I make quick decisions without thinking enough about consequences.
8. My relationships with people are made difficult by my tendency to talk first and
think later.
9. My moods have highs and lows.
10. I have trouble planning in what order to do a series of tasks or activities.
11. I easily become upset.
12. I seem to be thin skinned and many things upset me.
13. I almost always am on the go.
14. I am more comfortable when moving than when sitting still.
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15. In conversations, I start to answer questions before the questions have been
fully asked.
16. I usually work on more than one project at a time, and fail to finish many of
them.
17. There is a lot of "static" or "chatter" in my head.
18. Even when sitting quietly, I am usually moving my hands or feet.
19. In group activities it is hard for me to wait my turn.
20. My mind gets so cluttered that it is hard for it to function.
21. My thoughts bounce around as if my mind were a pinball machine.
22. My brain feels as if it were a television set with all the channels going at
once.
23. I am unable to stop daydreaming.
24. I am distressed by the disorganized way my brain works.
Autism Quotient: Please read each statement and select the appropriate
response
1. I prefer to do things with others rather than on my own.
2. I prefer to do things the same way over and over again.
3. If I try to imagine something, I find it very easy to create a picture in my mind.
4. I frequently get so strongly absorbed in one thing that I lose sight of other
things.
5. I often notice small sounds when others do not.
6. I usually notice car number plates or similar strings of information.
7. Other people frequently tell me that what I’ve said is impolite, even though I
think it is polite.
8. When I’m reading a story, I can easily imagine what the characters might look
like.
9. I am fascinated by dates.
10. In a social group, I can easily keep track of several different people’s
conversations.
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11. I find social situations easy.
12. I tend to notice details that others do not.
13. I would rather go to a library than a party.
14. I find making up stories easy.
15. I find myself drawn more strongly to people than to things.
16. I tend to have very strong interests which I get upset about if I can’t pursue.
17. I enjoy social chit-chat.
18. When I talk, it isn’t always easy for others to get a word in edgeways.
19. I am fascinated by numbers.
20. When I’m reading a story, I find it difficult to work out the characters’
intentions.
21. I don’t particularly enjoy reading fiction.
22. I find it hard to make new friends.
23. I notice patterns in things all the time.
24. I would rather go to the theatre than a museum.
25. It does not upset me if my daily routine is disturbed.
26. I frequently find that I don’t know how to keep a conversation going.
27. I find it easy to “read between the lines” when someone is talking to me.
28. I usually concentrate more on the whole picture, rather than the small details.
29. I am not very good at remembering phone numbers.
30. I don’t usually notice small changes in a situation, or a person’s appearance.
31. I know how to tell if someone listening to me is getting bored.
32. I find it easy to do more than one thing at once.
33. When I talk on the phone, I’m not sure when it’s my turn to speak.
34. I enjoy doing things spontaneously.
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35. I am often the last to understand the point of a joke.
36. I find it easy to work out what someone is thinking or feeling just by looking at
their face.
37. If there is an interruption, I can switch back to what I was doing very quickly.
38. I am good at social chit-chat.
39. People often tell me that I keep going on and on about the same thing.
40. When I was young, I used to enjoy playing games involving pretending with
other children.
41. I like to collect information about categories of things (e.g. types of car, types
of bird, types of train, types of plant, etc.).
42. I find it difficult to imagine what it would be like to be someone else.
43. I like to plan any activities I participate in carefully.
44. I enjoy social occasions.
45. I find it difficult to work out people’s intentions.
46. New situations make me anxious.
47. I enjoy meeting new people.
48. I am a good diplomat.
49. I am not very good at remembering people’s date of birth.
50. I find it very easy to play games with children that involve pretending.

Demographic Information:
Date of birth
Handedness: (Left/Right)
Biological Sex:
[ ] Male
[ ] Female
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[ ] Other

Ethnicity:
[ ] Hispanic or Latino/a
[ ] Not Hispanic or Latino/a

Race: {could select multiple}
[ ] American Indian/Alaskan Native
[ ] Asian
[ ] Black/African American
[ ] Native Hawaiian/Other Pacific Islander
[ ] White/Caucasian
[ ] Unknown/Do not wish to say

Details of any known problems with vision or hearing (e.g., colour blindness):
Have you ever been diagnosed with:
Any learning disability(e.g., dyslexia, auditory processing disorder, dyscalculia)?
(Yes/No)
Attention deficit disorder? (Yes/No)
Any autism spectrum disorder (e.g., Asperger’s)? (Yes/No)
If you answered ‘yes’ to any of the above, please provide information about your
specific diagnosis here:
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APPENDIX B
EXAMPLE STIMULI FOR THE COGNITIVE ASSESSMENTS

Figure B1. Example stimuli for the Vigilance task (as provided by
Neurobehavioral Systems).
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Figure B2. Example stimuli for the Flanker Task (as provided by Neurobehavioral
Systems)
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Figure B3. Example stimuli for the Match to Sample Task (as provided by
Neurobehavioral Systems)
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Figure B4. Example stimuli for Berg’s Card Sorting Task (as provided by
Neurobehavioral Systems).
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Figure B5. Example stimuli for the Iowa Gambling Task (as provided by
Neurobehavioral Systems).
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Figure B6. Example stimuli for the Change Detection Task (as seen in Fukuda
and Vogel et al., 2019)
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.222 *

-.221

1

.593 **

.533 **

.283 *

.885 **

.535 **

-.034

-.169

.187

-.241

.329 **

-.050

-.036

-.272

Emotional
Memory Positive

.021

-.127

-.061

-.168

-.082

-.156

.081

.179

-.054

-.028

-.213

-.007

.223

*

-.197

.593

**

1

**

.219

.900

**

.502

**

.088

.046

.065

-.087

.251

*

-.061

.056

-.208

Emotional
Memory Neutral

.081

.155

.081

-.077

.011

.054

-.037

.087

-.042

.074

-.156

.141

.145

.196

-.062

.179

-.004

.533

**

1

.193

.602

**

.796

**

.014

-.152

.149

-.304

*

.288

*

.128

-.036

-.166

*

*

**

-.079

.366

**

.747

**

*

*

.369 **

-.252 *

.261 *

**

-.091

.347

**

Emotional
Memory
Distractor
Emotional
Memory
Emotional Words
Emotional
Memory NonEmotional Words
IGT HRHR

-.520

-.224

-.230

-.296

-.124 -.248

.364

-.412

**

-.320

.397

*

.108

.052

.119

-.250

-.050

-.010

-.014

-.007

-.077

.014

-.191

.027

.271

.072

-.018

.072

-.169

-.025

-.085

.021

.194

-.019

.047

-.210

.139

.267 *

.121

.137

.128

-.207

-.023

.030

-.035

.059

-.077

.062 -.224 *

.112

.265

*

.483

.367

.316

.328

**

-.235

*

.242

.542

**

.542

.366

.487

-.050

.283

*

.219

.193

1

.280

-.204

.055

.163

.222

-.057

.043

-.288

-.234 *

.885 **

.900 **

.602 **

.280 *

1

.580 **

.032

-.064

.137

-.179

.325 **

-.063

.014

-.261

-.034

.535

**

1

-.155

-.224

.133

-.107

.332

**

.058

.000

-.289

**

-.522

**

**

.240

**

.502

**

.796

**

.747

**

*

.580

*

.347

-.275

-.084

-.170

.024

.076

-.051

-.153

-.244

-.142

.170

.232

-.013

-.125

.117

-.092

.210

-.044

.092

-.034

.088

.014

-.275

.032

-.155

1

-.085

-.008

.076

IGT
Disadvantageous
last half
IGT
Disadvantageous
Comparison
IGT FRHR

-.129

-.273 *

-.108

.033

-.102

-.242

-.204

-.085

.214

.205

.058

-.278 *

.124

-.005

.187

.007

.017

-.169

.046

-.152

-.204

-.064

-.224

.860 **

1

-.702 **

.151

-.141

-.033

.033

.300

.101

.222

.124

-.073

.193

.135

.097

.012

-.155

-.106

-.114

.355

**

.114

.049

-.123

.072

-.008

.187

.065

.149

.055

.137

.133 -.522 **

**

1

*

.116

-.034

.006

-.214

-.071

-.166

-.242

-.087

-.086

-.143

.100

.121

.061

-.075

.130

-.263

*

-.005

.170

-.065

.099

-.148

-.241

-.087

-.304

*

.163

-.179

-.107 -.375 **

Memory Capacity
Estimate

.161

.002

.097

-.227

*

.048

-.166

.147

.005

-.234

-.167 -.395 **

.372

**

-.107

**

-.185

.329

*

.288

*

**

.017

-.196

-.291

**

-.141

-.086

.011

-.120

-.011

-.056

.022

.057

-.151

.018

-.008

.100

-.138

-.050

-.061

.128

-.057

Flanker
Comparison RT

-.094

-.115

-.028

.053

.080

-.076

.181

.065

-.180

-.184 -.271 *

-.032

.074

.013

.050

-.022

.027

-.036

.056

-.036

Days Since
Having COVID-19

-.164

-.276

-.227

-.341 *

-.162

-.089

.003

-.128

-.196

-.057

.000

.066

.054

.158

-.086

.154

-.272

-.208

-.166

Flanker
Comparison Acc

-.320

*

.225

**

.478

**

.528

.487

**

.251

.860

-.702

.151

-.263

*

-.375

-.263

1

-.086

-.043

-.086

.099

**

-.085

-.141

.116

-.086

1

-.115

.199

-.222

-.063

.058

-.008

-.033

-.034

-.043

-.115

1

-.279

.043

.014

.000

.076

.033

.006

-.086

.199

-.279

-.288

-.261

-.289

.240

.300

-.214

.099

-.222

.222

*

.325

**

.332

*

.263

*

1

-.225

.263

-.225

1

